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                                                     1. INTRODUCTION 
 
1.1 CHROMATOGRAPHY1: 
 Chromatography is a valuable technique for the separation, purification, and 
identification of the constituents in a mixture. This technique was originally confined to 
the seperation of coloured substances such as plant pigments and dyestuffs. But the 
technique is now well applied to colourless substances also.  
 The chromatographic technique was first invented by M.TSWETT in 1906. The 
term chromatography (greek :- khromatos – colour and graphos – written) and its 
principles were first discovered by Michel Tswett . 
 On the general progress of science, chromatography may be regarded as an 
analytical technique employed for the purification and separation of organic and 
inorganic substances. It is also found useful for the fractionation of complex mixture, 
separation of closely related compound such as isomers and in the isolation of unstable 
substances.   
 
Principles of chromatographic separation2: 
• Adsorption chromatography: A solid stationary phase and a liquid or gaseous 
mobile phase. 
• Partition chromatography: A liquid stationary phase and a liquid or gaseous 
mobile phase. 
• Ion exchange chromatography: A solid polymeric stationary phase containing 
replaceable ions. 
• Size exclusion chromatography: An inert gel which acts as a molecular sieve, and 
liquid mobile phase. 
 
Adsorption chromatography: 
 In adsorption chromatography, the mobile phase containing the dissolved solutes 
which are passed over the surface of stationary phase, due to the affinity of the solute 
towards mobile or stationary phase, solutes gets separated.  In normal phase the mobile 
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phase is non polar and the stationary phase is polar where in reverse phase the mobile 
phase is polar and the stationary phase is non polar. 
 
Partition chromatography: 
 In partition chromatography the principle of separation is readily understood by 
considering the partitioning behaviour of substance between two immiscible liquids. Few 
substances, when shaken with two immiscible liquids, partition take place completely in 
to one or other  liquid.  Instead, most distribute them selves between the liquids such that 
the partition coefficient (the ratio of concentrations of the substance in each phase) is a 
constant value independent of the total amount, provided neither phase is saturated with 
the substance. 
 
Mode of chromatographic operations3: 
 There are three modes of chromatographic operation they are as follows: 
• Elution techniques 
- Isocratic method 
- Gradient method 
• Frontal techniques 
• Displacement techniques 
 
Types of chromatography techniques: 
 
• Planar chromatography 
• Column chromatography 
 
TYPES OF LIQUID CHROMATOGRAPHY4 
• Liquid – Solid chromatography 
• Liquid – liquid chromatography 
• Gas liquid chromatography 
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These three types are the basic types of chromatography and these are modified to 
different types of chromatography.  They are as follows: 
• Normal phase chromatography 
• Reverse phase chromatography 
• High performance liquid chromatography 
• Ion exchange chromatography 
• Size exclusion liquid chromatography 
• Super critical fluid chromatography 
• Chiral chromatography 
• Affinity chromatography 
 
1.2. HIGH PERFORMANCE LIQUID CHROMATOGRAPHY5: 
              The modern form of column chromatography has been called high performance, 
high pressure, and high-resolution and high-speed liquid chromatography. 
High-Performance Liquid Chromatography (HPLC) is a special branch of column 
chromatography in which the mobile phase is forced through the column at high speed.  
As a result the analysis time is reduced by 1-2 orders of magnitude relative to classical 
column chromatography and the use of much smaller particles of the adsorbent or support 
becomes possible increasing the column efficiency substantially.   
HPLC has the following important features. 
• High resolution power 
• Speedy separation 
• Continuous monitoring of the column effluents  
• Accurate quantitative measurement 
• Repetitive and reproducible analysis, using the same columns 
Automation of the analytical procedure and date handling 
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Normal Phase Chromatography 
In normal phase chromatography, the stationary phase is a polar adsorbent and the mobile 
phase is generally a mixture of non-aqueous solvents. 
         The silica structure is saturated with silanol groups at the end. These OH groups are 
statistically disturbed over the whole of the surface. The silanol groups represent the 
active sites (very polar) in the stationary phase. This forms a weak type of bond with any 
molecule in the vicinity when any of the following interactions are present. 
♦ Dipole-induced dipole 
♦ Dipole-dipole 
♦ Hydrogen bonding 
♦ pi-Complex bonding 
 These situations arise when the molecule has one or several atoms with lone pair 
electron or a double bond. The absorption strengths and hence k’ values (elution series) 
increase in the following order. Saturated hydrocarbon < olefins < aromatics < organic 
halogen compounds < sulphides < ethers< esters < aldehydes and ketones < amines < 
sulphones < amides < carboxylic acids. The strength of interactions depends not only on 
the functional groups in the sample molecule but also on steric factors. If a molecule has 
several functional groups, then the most polar one determines the reaction properties. 
 Chemically modified silica, such as the aminopropyl, cyanopropyl and diol phases 
is useful alternatives to silica gel as stationary phase in normal phase chromatography. 
 The aminopropyl and cyanopropyl phases provide opportunities for specific 
interactions between the analyte and the stationary phases and thus offer additional 
options for the optimizations of separations. Other advantages of bonded phases lie in 
their increased homogeneity of the phase surface. 
          Resolution with water in weak mobile phase may be most conveniently achieved 
by drying the solvents and then adding a constant concentration of water or some very 
polar modifier such as acetic acid or trietylamine (TEA) to the mobile phase. The 
addition of such polar modifiers serves to deactivate the more polar shape as well as the 
reproducibility of the retention times. 
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Reversed Phase Chromatography 
          In 1960’s chromatographers started modifying the polar nature of silanol group by 
chemically reacting silica with organic silanes. The objective was to make less polar or 
non polar so that polar solvents can be used to separate water-soluble polar compounds. 
Since the ionic nature of the chemically modified silica is now reversed i.e. it is non-polar 
or the nature of the phase is reversed. The chromatographic separation carried out with 
such silica is referred to as reversed- phase chromatography. 
           A large number of chemically bonded stationary phases based on silica are 
available commercially. Table 1 lists some of the functional groups bonded in chemically 
modified silica. Silica based stationary phases are still most popular in reversed phase 
chromatography however other absorbents based on polymer (styrene-divinyl benzene 
copolymer) are slowly gaining ground. 
         Simple compounds are better retained by the reversed phase surface, the less water- 
soluble (i.e. the more non-polar) they are. The retention decreases in the following order: 
aliphatics > induced dipoles (i.e.,CCl4) > permanent dipoles (e.g.CHCl3) > weak lewis 
bases (ethers, aldehydes, ketones) > strong lewis bases (amines) > weak lewis acids 
(alcohols, phenols) > strong lewis acids (carboxylic acids). Also the retention increases as 
the number of carbon atoms increases. 
          As a general rule the retention increases with increasing contact area between 
sample molecule and stationary phase i.e., with increasing number of water molecules, 
which are released during the adsorption of a compound. Branched chain compounds are 
eluted more rapidly than their corresponding normal isomers. 
          In reversed phase systems the strong attractive forces between water molecules 
arising from the 3-dimentional inter molecular hydrogen bonded network, from a 
structure of water that must be distorted or disrupted when a solute is dissolved. Only 
higher polar or ionic solutes can interact with the water structure. Non- polar solutes are 
squeezed out of the mobile phase and are relatively insoluble in it but with the 
hydrocarbon moieties of the stationary phase. 
          Chemically bonded octadecyl silane (ODS) an alkaline with 18 carbon atoms it is 
the most popular stationary phase used in pharmaceutical industry. Since most 
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pharmaceutical compounds are polar and water soluble, the majority of HPLC methods 
used for quality assurance, decomposition studies, quantitative analysis of both bulk 
drugs and their formulations use ODS HPLC columns. The solvent strength in reversed 
phase chromatography is reversed from that of adsorption chromatography (silica gel) as 
stated earlier. Water interacts strongly with silanol groups, so that adsorption of sample 
molecules become highly restricted and they are rapidly eluted as a result. Exactly 
opposite applies in reversed phase system; water cannot wet the non-polar (hydrophobic) 
alkyl groups such as C18 of ODS phase and therefore does not interact with the bonded 
moiety. Hence water is the weakest solvent of all and gives slowest elution rate. The 
elution time (retention time) in reversed phase chromatography increases with increasing 
amount of water in the mobile phase. 
 The essential equipment consists of an eluent, reservoir, a high-pressure pump, 
and an injector for introducing the sample, a column containing the stationary phase, a 
detector and recorder. The development of highly efficient micro particulate bonded 
phases has increased the versatility of the technique and has greatly improved the 
analysis of multicomponent mixtures. 
 The systems used are often described as belonging to one of four mechanistic 
types, adsorption, partition, ion exchange and size-exclusion. Adsorption chromatography 
arises from interaction between solutes on the surface of the solid stationary phase. 
Partition chromatography involves a liquid stationary phase, which is immiscible with the 
eluent and coated on an inert support. Adsorption and partition systems can be normal 
phase (stationary phase more polar than eluent) or reversed phase (stationary phase less 
polar than eluent). Ion-exchange chromatography involves a solid stationary phase with 
anionic or cationic groups on the surface to which solute molecules of opposite charge 
are attracted. Size-exclusion chromatography involves a solid stationary phase with 
controlled pore size. Solutes are separated according to their molecular size, the large 
molecules enable to enter the pores eluting first.  
The various components of a HPLC system are herewith described. 
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                    Fig.No.1. Schematic diagram of the HPLC system 
 
Instrumentation6,7 
Solvent delivery system 
The mobile phase is pumped under pressure from one or several reservoirs and 
flows through the column at a constant rate. With micro particulate packing, there is a 
high-pressure drop across a chromatography column. Eluting power of the mobile phase 
is determined by its overall polarity, the polarity of the stationary phase and the nature of 
the sample components. For normal phase separations eluting power increases with 
increasing polarity of the solvent but for reversed phase separations, eluting power 
decreases with increasing solvent polarity. Optimum separating conditions can be 
achieved by making use of mixture of two solvents. Some other properties of the 
solvents, which need to be considered for a successful separation, are boiling point, 
viscosity, detector compatibility, flammability and toxicity. 
The most important component of HPLC in solvent delivery system is the pump, 
because its performance directly effects the retention time, reproducibility and detector 
sensitivity. Among the several solvent delivery systems (direct gas pressure, pneumatic 
intensifier, reciprocating etc.) reciprocating pump with twin or triple pistons is widely 
used, as this system gives less baseline noise, good flow rate reproducibility etc. 
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Solvent degassing system 
The constituents of the mobile phase should be degassed and filtered before use. 
Several methods are employed to remove the dissolved gases in the mobile phase. They 
include heating and stirring, vacuum degassing with an aspirator, filtration through 0.45µ 
filter, vacuum degassing with an air-soluble membrane, helium purging ultra sonication 
or purging or combination of these methods. HPLC systems are also provided an online 
degassing system, which continuously removes the dissolved gases from the mobile 
phase. 
 
Gradient elution devices 
HPLC columns may be run isocratically, i.e., with constant eluent or they may be 
run in the gradient elution mode in which the mobile phase composition varies during 
run. Gradient elution is a means of over  coming the problem of dealing with a complex 
mixture of solutes.  
 
Sample introduction systems 
Two means for analyte introduction on the column are injection in to a flowing 
stream and a stop flow injection. These techniques can be used with a syringe or an 
injection valve. Automatic injector is a microprocessor-controlled version of the manual 
universal injector. Usually, up to 100 samples can be loaded in to the auto injector tray. 
The system parameters such as flow rates, gradient, run time, volume to be injected, etc. 
are chosen, stored in memory and sequentially executed on consecutive injections.  
 
Liquid chromatographic detectors8,9 
The function of the detector in HPLC is to monitor the mobile phase as it emerges 
from the column. Generally, there are two types of HPLC detectors, bulk property 
detectors and solute property detectors.  
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Bulk property detectors 
  These detectors are based on differential measurement of a property, which is 
common to both the sample and the mobile phase. Examples of such detectors are 
refractive index, conductivity and dielectric constant detectors. 
 
Solute property detectors 
  Solute property detectors respond to a physical property of the solute, which is not 
exhibited by the pure mobile phase. These detectors measure a property, which is specific 
to the sample, either with or without the removal of the mobile phase prior to the 
detection. Solute property detectors which do not require the removal of the mobile phase 
before detection include spectrophotometric (UV or UV-Vic) detector, fluorescence 
detectors, polarographic, electro-chemical and radio activity detectors, whilst the moving 
wire flame ionization detector and electron capture detector both require removal of the 
mobile phase before detection. 
                    UV-Vis and fluorescent detectors are suitable for gradient elution, because 
many solvents used in HPLC do not absorb to any significant extent. 
 
Column and Column-packing materials10 
The heart of the system is the column.  In order to achieve high efficiency of 
separation, the column material (micro-particles, 5-10 µm size) packed in such a way that 
highest numbers of theoretical plates are possible.   
 Silica (SiO2,H2O) is the most widely used substance for the manufacture of 
packing materials. It consists of a network of siloxane linkages (Si-O-Si) in a rigid three 
dimensional structure containing inter connecting pores. Thus a wide range of 
commercial products is available with surface areas ranging from 100 to 800 m2/g. and 
particle sizes from 3 to 50 µm.   
 The silanol groups on the surface of silica give it a polar character, which is 
exploited in adsorption chromatography using non-polar organic eluents. Silica can be  
drastically altered by reaction with organo chloro silanes or organo alkoxy silanes giving 
Si-O-Si-R linkages with the surface. The attachment of hydrocarbon change to silica 
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produces a non-polar surface suitable for reversed phase chromatography                                        
where mixtures of water and organic solvents are used as eluents. The most popular 
material is octadecyl-silica (ODS-Silica), which contains C18 chains, but materials with 
C2, C6, C8 and C22 chains are also available. During manufacture, such materials may be 
reacted with a small mono functional silane (e.g. trimethyl chloro silane) to reduce 
further the number of silanol groups remaining on the surface (end-capping). There is a 
vast range of materials which have intermediate surface polarities arising from the 
bonding to silica of other organic compounds which contain groups such as phenyl, nitro, 
amino and hydroxyl. Strong ion exchangers are also available in which sulphonic acid 
groups or quaternary ammonium groups are bonded to silica. The useful pH range for 
columns is 2 to 8, since siloxane linkages are cleaved below pH-2 while at pH values 
above eight silica may dissolve. 
                    In HPLC, generally two types of columns are used, normal phase columns 
and reversed phase columns. Using normal phase chromatography, particularly of non-
polar and moderately polar drugs can make excellent separation. It was originally 
believed that separation of compounds in mixture takes place slowly by differential 
adsorption on a stationary silica phase. However, it now seems that partition plays an 
important role, with the compounds interacting with the polar silanol groups on the silica 
or with bound water molecules.  
                    While normal phase seems the passage of a relatively non-polar mobile  
phase over a polar stationary phase, reversed phase chromatography is carried out using a 
polar mobile phase such as methanol, Acetonitrile, water, buffers etc., over a non-polar 
stationary phase. Ranges of stationary phases (C18, C8, -NH2, -CN, -phenyl etc.) are 
available and very selective separations can be achieved. The pH of the mobile phase can 
be adjusted to suppress the ionization of the drug and thereby increase the retention on 
the column. For highly ionized drugs ion-pair chromatography is used. 
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Table 1.Bonded Phases for HPLC and their Abbreviations   
Phase Description 
Si  
Silica       
Classic normal phase material. Suitable for separating polar non-ionic organic 
compounds. 
C1 TMS, SAS,  
Trimethyl silane         
 
Reversed phase material. Unique selectivity for polar and multifunctional 
compounds. Least retentive of all alkyl group bonded phases for non-polar solvents.  
C2 RP-2, Dimethyl 
                                       
Reversed phase material, less retentive than C4, C8, or C18. More retentive than C1. 
C3 Propyl 
 
Reversed phase material, used in hydrophobic interaction chromatography (HIC) of 
proteins and peptides. 
C4 Butyl 
           
Reversed phase material, useful for ion-pairing chromatography offers less retention 
than C8 and C18 phases for non-polar solutes. When bonded to 300 Å silica, it is an 
ideal phase for analyzing large proteins and hydrophobic peptides. 
C6 Hexyl 
 
Reversed phase material, useful for ion-pairing chromatography. Less retentive than 
C8 and C18 phases. 
Si OH
 
Si CH3 
 
C2H5 Si 
 
Si C3H7 
 
Si C4H9 
 
Si C6H13 
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C8 MOS, RP-8, LC8, Octyl 
 
 
Reversed phase material, similar selectivity to C18 but less retentive. Wide 
applicability (e.g. pharmaceuticals, nucleosides, steroids). When bonded to300 Å 
silica, it is an ideal phase for peptides, peptide mapping and small hydrophilic 
proteins. 
     C18 ODS, RP-18, LC18, Octadecyl 
Classic reversed phase material is most retentive for non-polar solutes and is 
excellent for ion-pairing chromatography. It is having wide applicability for the 
assay of nucleosides, nucleotides, steroids, pharmaceuticals, vitamins, fatty acids 
and environmental compounds when bonded to 300 Å silica, this phase is perfect 
for separating small hydrophilic peptides. 
 
Derivatization 
In HPLC derivatization is used to enhance the sensitivity and selectivity of 
detection when available detectors are not satisfactory for the underivatized compounds. 
Both ultra violet absorbing and fluorescence derivatives have been widely used. Ultra 
violet derivatization reagents include N-succinimidyl p-nitro phenyl acetate, phenyl 
hydrazine and 3, 5-dinitro benzyl chlorides, while fluorescent derivatives can be formed 
with reagents such as dansyl chloride, 4-bromo methyl-7-methoxy-coumarin and 
fluorescamine. Derivative formation can be carried out before the sample is injected on to 
the column or by online chemical reactions between the column out let and the detector. 
Gradient elution 
                   Gradient elution or solvent programming is the change of solvent 
composition during a separation in which the solvent strength increases from the 
beginning to the end of the separation. It is well suited to the analysis of samples of 
unknown complexity since good resolution is automatically provided for a wide range of  
 
Si C8H17 
 
Si C18H 37 
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sample polarities. There are two types of gradient systems: Low-pressure gradient 
mixtures and high- pressure gradient mixtures. In the former the solvents are mixed at 
atmosphere pressure and then pumped to the column, where as in the later, solvents are 
pumped in to a mixing chamber at high pressure before going in to the column. 
 
 1.3. METHOD DEVELOPMENT AND OPTIMIZATION11 
During the optimization stage, the initial sets of conditions that have evolved from 
the first stages of development are improved or maximized in terms of resolution and 
peak shape, plate counts asymmetry, capacity, elution time, detection limits, limit of 
Quantitation, and overall ability to quantify the specific analyte of interest. 
Optimization of a method can follow either of two general approaches:  
1. Manual  
2. Computer driven  
The manual approach involves varying one experimental variable at a time, while 
holding all others constant, and recording changes in response .The variables might 
include flow rates, mobile or stationary phase composition, temperature, detection 
wavelength, and pH this univariate approach to system optimization is slow, time 
consuming and potentially expensive. However, it may provide a much better 
understanding of the principles and theory involved and of interactions of the variables.  
In the second approach, computer driven automated methods development, 
efficiency is optimized while experimental input is minimized. Computer driven 
automated approaches can be applied to many applications .In addition, they are capable 
of significantly reducing the time, energy and cost of virtually all-instrumental methods 
development.  
The various parameter s that include to be optimized during method development 12 
1. Mode of separation  
2. Selection of stationary phase  
3. Selection of mobile phase 
4. Selection of detector  
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1.3.1 Selection of mode of separation  
In reverse phase mode, the mobile phase is comparatively more polar than the 
stationary phase. For the separation of polar or moderately polar compounds, the most 
preferred mode is reverse phase. The nature of the analyte is the primary factor in the 
selection of the mode of separation. A second factor is the nature of the matrix. 
 
1.3.2. Selection of stationary phase / column  
Selection of the column is the first and the most important step in method 
development the appropriate choice of separation column includes three different 
approaches  
1. Selection of separation system  
2. The particle size and the nature of the column packing 
3. The physical parameters of the column i.e. the length and the diameter  
Some of the important parameters considered while selecting chromatographic columns 
are 
♦ Length and diameter of the column. 
♦ Packing material. 
♦ Shape of the particles. 
♦ Size of the particles. 
♦ % of Carbon loading 
♦ Pore volume. 
♦ Surface area. 
♦ End capping. 
The column is selected depending on the nature of the solute and the information 
about the analyte. Reversed phase mode of chromatography facilitates a wide range of 
columns like dimethyl silane (C2), butylsilane (C4), octylsilane (C8), octadecylsilane 
(C18), base deactivated silane (C18) BDS phenyl, cyanopropyl (CN), nitro, amino etc. C18    
was chosen for this study since it is most retentive one. The sample manipulation 
becomes easier with this type of column  
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                   Generally longer columns provide better separation due to higher theoretical 
plate numbers. As the particle size decreases the surface area available for coating 
increases. Columns with 5-µm particle size give the best compromise of efficiency, 
reproducibility and reliability. In this case, the column selected had a particle size of 5 
µm and a internal diameter of 4.6 mm 
                   Peak shape is equally important in method development. Columns that 
provide symmetrical peaks are always preferred while peaks with poor asymmetry can 
result in, 
♦ In accurate plate number and resolution measurement 
♦ Imprecise quantitation  
♦ Degraded and undetected minor bands in the peak tail 
♦ Poor retention reproducibility 
A useful and practical measurement of peak shape is peak asymmetry factor and peak 
tailing factor. Peak asymmetry is measured at 10% of full peak height and peak tailing 
factor at 5%. Reproducibility of retention times and capacity factor is important for 
developing a rugged and repeatable method. 
               A column which gives separation of all the impurities and degradants from 
each other and from Analyte peak and which is rugged for variation in mobile phase shall 
be selected. 
 
 
1.3.3. Selection of mobile phase  
The primary objective in selection and optimization of mobile phase is to achieve 
optimum separation of all the individual impurities and degradants from each other and 
from analyte peak 
            In liquid chromatography, the solute retention is governed by the solute 
distribution factor, which reflects the different interactions of the solute – stationary 
phase, solute – mobile phase and the mobile phase – stationary phase .For a given 
stationary phase, the retention of the given solute depends directly upon the mobile 
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phase, the nature and the composition of which has to be judiciously selected in order to 
get appropriate and required solute retention. The mobile has to be adapted in terms of 
elution strength (solute retention) and solvent selectivity (solute separation) Solvent 
polarity is the key word in chromatographic separations since a polar mobile phase will 
give rise to low solute retention in normal phase and high solute retention in reverse 
phase LC. The selectivity will be particularly altered if the buffer pH is close to the pKa 
of the analytes; the solvent strength is a measure of its ability to pull analyte from the 
column. It is generally controlled by the concentration of the solvent with the highest 
strength. 
The following are the parameters, which shall be taken into consideration while 
selecting and optimizing the mobile phase. 
♦ Buffer 
♦ pH of the buffer  
♦ Mobile phase composition. 
 
1.3.3.1. Buffer, if any and its length. 
Buffer and its strength play an important role in deciding the peak symmetries and 
separations. Some of the most, commonly employed buffers are  
♦ Phosphate buffers prepared using salts like KH2PO4, 
K2HPO4,NaH2PO4,Na2HPO4,etc 
♦ Phosphoric acid buffers prepared using H3PO4. 
♦ Acetate buffers – Ammonium acetate, Sodium acetate, etc. 
♦ Acetic acid buffers prepared using  CH3COOH. 
           The retention times also depend on the molar strengths of the buffer – 
Molar strength is increasingly proportional to retention times. The strength of the buffer 
can be increased, if necessary, to achieve the required separations. 
               The solvent strength is a measure of its ability to pull analytes from the column. 
It is generally controlled by the concentration of the solvent with the highest strength. 
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1.3.3.2. pH of the buffer 
pH plays an important role in achieving the chromatographic separations as it 
controls the elution properties by controlling the ionization characteristics. Experiments 
were con ducted using buffers having different pH to obtain the required separations. 
It is important to maintain the pH of the mobile phase in the range of 2.0 to 8.0 as 
most columns does not withstand to the pH which are outside this range. This is due to 
the fact that the siloxane linkage area cleaved below pH 2.0, while pH valued above 8.0 
silica may dissolve. 
 
1.3.3.Mobile phase composition: 
Most chromatographic separations can be achieved by choosing the optimum mobile 
phase composition. This is due to that fact that fairly large amount of selectivity can be 
achieved by choosing the qualitative and quantitative composition of aqueous and 
organic portions. Most widely used solvents in reverse phase chromatography are 
Methanol and Acetonitrile. Experiments were conducted with mobile phases having 
buffers with different pH and different organic phases to check for the best separations 
between the impurities. A mobile phase which gives separation of all the impurities and 
degradants from each other and from Analyte peak and which is rugged for variation of 
both aqueous and organic phase by at least ±0.2% of the selected mobile phase 
composition. 
1.3.4. Selection of detector:  
The detector was chosen depending upon some characteristic property of the analyte like 
UV absorbance, fluorescence, conductance, oxidation, reduction etc. characteristics that 
are to be fulfilled by a detector to be used in HPLC determination are, 
♦ High sensitivity, facilitating trace analysis 
♦ Negligible baseline noise. To facilitate lower detection 
♦ Large linear dynamic range  
♦ Low dead volume 
♦ Non destructive to sample  
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♦ Inexpensive to purchase and operate  
              Pharmaceutical ingredients do not all absorb UV light equally, so that selection 
of detection wavelength is important. An understanding of the UV light absorptive 
properties of the organic impurities and the active pharmaceutical ingredient is very 
helpful. 
                    For the greatest sensitivity λmax should be used. UV wavelengths below 200 
nm should be avoided because detector noise increases in this region. Higher 
wavelengths give greater selectivity. 
                   
                   VALIDATION OF ANALYTICAL METHOD DEVELOPMENT 
 
Introduction: 
          Analytical method validation13,14 is the process of demonstrating that 
analytical procedures are suitable for their intended use and provide accurate test results 
that evaluate a product against its defined specification and quality attributes. 
            It is process involving confirmation or establishing by laboratory studies 
the method / procedure/ system/ analyte gives accurate and reproducible result for 
intended application in a proven and established range. That performance characteristic 
of the method (accuracy, precession,  sensitivity, ruggedness etc).. 
 
Types of validation:15 
Prospective Validation: At least three successive production size (US Via) batches, all 
batches made tested and report approved before distribution facilities and equipment 
qualified. 
Concurrent Validation: Generation of validation data concurrent or simultaneously with 
normal production schedules used in exceptional cases (low volume products); interim 
reports required. 
Retrospective Validation: This is establishing documented evidence that the process is 
performed satisfactorily and consistently over time, based on review and analysis of 
historical data. The source of such data is production and QA/QC records. The issues to 
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be addressed here are charged to equipment, process, specification and other relevant 
changes in the past. 
 
1.4.1 VALIDATION OF ANALYTICAL PROCEDURES 16,17 
Definitions, Methodology and Acceptance Criteria: 
Different Types of Validation characteristics: 
 Precision           
 Accuracy 
 Specificity and Selectivity 
 Linearity and Range 
 Solution stability 
 Limit of Detection (LOD) 
 Limit of Quantification (LOQ) 
 Robustness 
 Ruggedness. 
 System Suitability 
Generalized validation process for an HPLC assay method:  
 Validation2 is the process of collecting documented 
evidence that the method performs according to its intended purpose.  The validation 
process has been described as follows: 
1. Accuracy  
             Accuracy18 is the closeness of test results obtained by that method to the true 
value. The accuracy of an analytical method should be established across its range. There 
are several methods that can be used for determining accuracy. The most common 
include 
          Analyze a sample of known concentration and compare the measurement to the 
true value. In this case, method accuracy is the agreement between the difference in the 
measured analyte concentration and the known amount of analyte added. That is the 
accuracy or % recovered is calculated as:  
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                                     Cm × 100     
         Ct 
            Where   Cm  is the measured concentration  
                           Ct  is the theoretical concentration.            
Accuracy has also been reported as a sample is analyzed and the measured value should 
ideally be identical to the true value. Accuracy is represented and determined by recovery 
experiments. The usual range is being 10% above or below the expected range of claim. 
The % recovery was calculated using the formula, 
                                                                   (a + b) -a 
                      
 Percentage Recovery =                        
              b×100 
    Where, 
                    a – Amount of drug present in sample 
 b – Amount of standard added to the sample 
ICH states that accuracy should be assessed using a maximum 9 determination over a 
minimum of 3 concentration levels covering the specified range (eg. 3 concentration /3 
replicates each of the total analytical procedure).   
 
Acceptance Criteria: 
1.  For an assay method, mean recovery will be 100%± 2% at each concentration over the 
range of 80-120% of the target concentration. 
2. For an impurity method, mean recovery will be 0.1% absolute of the theoretical 
concentration or 10% relative, whichever is greater for impurities in the range of 0.1-2.5 
% (V/W). 
 
2. Precision:   
             Precision14,19 of an analytical procedure expressed the closeness of agreement       
(degree of scatter) between a series of measurement obtained from multiple samplings of 
the same homogeneous sample under prescribed condition. 
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The precision of test method is usually expressed as the standard deviation or relative 
standard deviation of a series of measurements. Precision may be considered at three 
levels: Repeatability, Intermediate Precision and Reproducibility. 
 
System precision:  
        A System precision was evaluated by measuring the peak response of drug for six 
replicate injection of the standard solution preparation as per the proposed method. 
 
Method precision:  
         The method precision was determined by preparing the sample of a single batch of 
the drug for tablet formulation six times and analysed as per the propsed method. 
 
Acceptance Criteria: 
1.Percentage Relative standard deviation (%RSD)  NMT 1 % (Instrument precision) 
2.(%RSD)  NMT -2% (Intra- assay precision) 
 
3. Specificity: Specificity19 is the ability to assess unequivocally the analyte in the 
presence of components which may be expected to be present. Typically these might 
include impurities, degradants, matrix, etc. Specificity shall be demonstrated by 
performing Placebo / blank interference and forced degradation studies. 
 
a. Blank interference:  
  Blank solution is prepared and analysed as per test method. 
 
b. Placebo interference (In case of Drug products):  
 The placebo solution equivalent to the test concentration is also prepared and 
analysed as per the test method. 
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4. Forced Degradation studies:  
           The sample is degraded forcefully under the various stress conditions like 
Light, heat, humidity, acid / base / water hydrolysis and oxidation to ensure the 
degradation ranging 1 % to 20 %. 
          
a) Light: The Drug product, drug substance and placebo are exposed to UV light for 
about 200 watt hours / square meter and the overall illumination not less than 1.2 million 
Lax hours  for visible light. The sample and placebo solution are prepared as per test 
method and analyzed. 
 
 b) Humidity: The Drug product, drug substance and placebo are exposed for about 80% 
RH at about 25°C for about one week. Prepare the sample and placebo solution as per test 
method and analyzed. 
          
c) Heat: The Drug product, drug substance and placebo are exposed at 105°C for about 
12 hours (For substance having low melting point below 10°C of its melting point). The 
sample and placebo solution are prepared as per test method and analyzed. 
          
d)  Acid / Base: The 0.1N acid or base solution of the drug refluxes the sample and 
placebo with 50 ml of acid / base solution for about 1 hour at 60°C. Neutralize the 
solution and dissolve the contents in diluents as per test method. Change the strength of 
acid and base or reflux time to ensure the desired degradation. 
          
e) Oxidation: The sample was refluxed for 12 hour at 60°C with 1 % H2O2 or suitable 
oxidant and dissolved the contents in diluents as per test method. The reflux time was 
changed so as to ensure the desired degradation. 
         
 f) Water: The sample / placebo was refluxed with 100 ml of purified water for 12 hour at 
60°C. Dissolve the contents in diluents as per test method. Change the reflux time so as 
to ensure the desired degradation. 
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Note: Based on the physic-chemical properties and literature stress conditions can be 
decided. 
 
Acceptance Criteria: 
1.Placebo / Blank should not elute at the retention time of analyte peak and known 
impurity peak. 
2.Peak purity of analyte peak should be confirmed. 
3.Degradation of active analyte peak should be from 1% to 20%.23 
 
5. Limit of Detection:  
 The limit of detection20 is the lowest concentration of analyte in a sample that can be 
detected but not necessarily determined in quantitatively using a specific method under 
the required experimental conditions. Such a limit is expressed in terms of concentration 
of analyte in the sample. 
 
Following are different approaches: 
1. Visual Evaluation Method: 
           The sample solutions have to be prepared with known lowest concentrations of 
analyte and establish the minimum concentration at which the analyte can be reliably 
detected by analyzing as per test method. 
a. Based on Signal to Noise Ratio Method: 
                  The LOD can be expressed as a concentration at specified signal-to-noise 
(S/N) ratio obtained from samples spiked with analyte. A signal-to-noise(S/N) ratio 
between 3:1 and 2:1 is generally considered acceptable. 
b. Based on the standard Deviation of the Response and the Slope: 
1. The blank solution has to be prepared as per test method and inject six times into the 
chromatographic system.2. Similarly the linearity solution staring from lowest possible 
concentration of analyte to 150 % (or as per protocol) of target concentration have to be 
prepared to establish the linearity curve. 
 The detection limit (DL) may be expressed as : 
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                        3.3 X Standard deviation of the response of the blank (σ) 
       LOD   =   
                                                                          Slope 
                S= slope of the calibration curve of the analyte. 
The slope shall be estimated from the calibration curve of the analyte. 
 
6. Limit Of Quantitation: 
              The limit of quantitation20 is the lowest concentration of the analyte in a sample 
that can be determined with acceptable precision and accuracy under the stated 
experimental conditions quantitation limit is expressed as the concentration of analyte 
(eg. Percentage, parts per million) in the sample. 
 
Following are different approaches:  
a.  Visual Evaluation Method: 
              The sample solutions with known lowest possible concentrations of analyte 
and establish the minimum concentration at which the analyte can be reliably 
quantified by analyzing as per test method. 
b. Based on signal to noise ratio method : 
              The LOQ can be expressed as a concentration at specified signal-to-noise ratio 
obtained from samples spiked with analyte. A signal-to-noise ratio of 10:1 is generally 
considered acceptable. The ratio recognized by the ICH (1996) is a general rule. It has 
been stated that “the determination of LOQ is a compromise between the concentration 
and the required precision and accuracy. That is, as the LOQ concentration level 
decreases, the precision increases. 
c. Based on the standard Deviation of the Response and the Slope: 
 The blank solution as per test method and inject six times into the chromatographic 
system. Similarly the linearity solution staring from lowest possible concentration of 
analyte to 150% (or as per protocol) of target concentration and establish the linearity 
curve. 
The limit of quantitation (LOQ) may be expressed as : 
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                                 10 X Standard deviation of the response of the blank(σ) 
                   LOQ =   
                                                                   Slope 
 The slope shall be estimated from the calibration curve of the analyte. 
 
Acceptance Criteria: 
1. In Pharmaceutical application, the LOQ is typically set at minimum 0.05% for active 
pharmaceutical ingredients. 
2.LOQ is defined as the lowest concentration providing a RSD of 5%. 
3.LOQ should be at least 10% of the minimum effective concentration for clinical 
applications. 
4.Signal -to- noise ratio is 10:1. 
7. Linearity and range:  
        Linearity: Linearity is the ability of the method to obtain test results that are 
directly proportional to the analyte concentration within a given range. 
        Range: Range of analytical procedure is the interval between the upper and lower 
concentration of analyte in the sample (including concentrations) for which it has been 
demonstrated that the analytical procedure has a sutable level of precision, accuracy, and 
linearity. 
Measurement: A range of standards should be prepared containing at least 5 different 
concentration of analyte which are approximately evenly spaced and span 50-150% of the 
label claim. 
             At least 6 replicates per concentration to be studied.  Plot a graph of 
concentration (on X-axis) Vs mean response (on Y-axis) calculates the regression 
equation. 
           Y – Intercept and correlation coefficient.  Plot another graph of concentration (on 
X-axis) Vs response ratio (replicate response divided by concentration on Y-axis). 
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The range of the method is validated by verifying that the analytical method provides 
acceptable precision, accuracy, and linearity when applied to sample containing analyte 
at the extreme of the range as well as within the range. 
Acceptance criteria: 
 Coefficient of correlation should be NLT 0.99. 
8. Ruggedness: 
           Degree of reproducibility of test results obtained by the analysis of the same 
sample under a verity of conditions, such as different laboratories, different analysts, 
different instruments etc. 
         Normally  expressed as the lack of influence on test results of operational and 
environmental variable of the analytical method. 
        Ruggedness is a measure of reproducibility of test results under the variation in 
condition normally expected from laboratory to laboratory and from analyst to analyst  
 The following are the typical method parameters need to tested during method       
      validation:  
 Analyst-to-Analyst variability. 
 Column-to-Column variability. 
 System-to-System variability. 
 Different days. 
 Different Laboratories. 
 Stability of Solutions and mobile phase.  ( At least for 48 hours ) 
9. Robustness: 
      Robustness of an analytical method is a measure of its capacity ti remain un 
affectedly small but deliberate variations  in method parameters and provides an 
indication of its reliability during normal usage. 
  For example a chromatographic method, the typical method parameters need to 
change deliberately and verify during method validation:  
    Flow rate   : (+/- 0.2ml/minutes). 
    Mobile phase composition         :       (+/- 10% of organic phase). 
    Column oven temperature  : (+/- 5°C). 
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     PH of buffer in mobile phase : (+/- 0.2 units). 
     Filter suitability   : (At least two filters). 
For Variations:  
 1. System suitability should meet the acceptance criteria as per test method.  
2. If system suitability doesn’t meet, the variation range is narrowed and carried out the 
experiment again to meet system suitability. 
10. SYSTEM SUITABILITY TESTING 
System suitability testing21 is an integral part of many analytical procedures. The tests are 
based on the concept that the equipment, electronics analytical operation and samples to 
be analyzed constitute an integral system that can be evaluated as such. System suitability 
test parameters to be established for a particular procedure depend on the type of 
procedure being validated. 
System Suitability Parameters 
 Tailing factor 
 Theoretical plate number 
 Theoretical plate per meter 
 Resolution factor 
 Capacity factor  
 Precision / Injection repeatability 
 Relative retention 
a. Tailing factor: 
Asymmetry factor13 of a peak was calculated from the following expression: 
      Peak tailing factor = 
A2
BA +
 
A – Left half of the peak at 5% peak height when the peak is bisected with a 
perpendicular line dropped from the maximum of peak interest. 
B – Right half of the peak at 5% peak height when the peak is bisected with a 
perpendicular line dropped from the maximum of peak interest. 
b. Theoretical plate number (N):14 
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The assessment of performance of column efficiency of a column is in terms of number 
of theoretical plate  
An equation shown below: 
                                 N = 5.54[t/wh/2] 
Where, 
t    = Retention time 
     Wh/2 = width of peak at half weight 
Theoretical plate number is a measure of column efficiency. i.e. how many peaks can 
be located per unit run time of the chromatogram ,‘H’ or ‘HETP’, the height equivalent 
to the theoretical plate, measures the column efficiency per unit length of the column. 
Parameters which can affect ‘N’ or ‘H’ include peak position particle size in column, 
flow rate of mobile phase and molecular weight of the analyte. 
c. Capacity factor:21 
It reflects the location of peak of interest with respect to the void volume i.e. elution time 
of the unretained compound. 
                                        K1= (tr-to)-to      
 
[tr – retention of analyte, to – retention of void or unretained component.] 
Methods used for the examination of pharmaceutical material may be broadly classified 
as; 
d. Resolution: 17 
R = 2 [(t2-t1)/ w2+w1] 
t2, t1 are the retention time 
w2, w1 are the peak width at base line respectively. 
Resolution is to measure how well the resulting two peaks are separated. For reliable 
quantitation well separated peaks are essential for quantitation. This is a very useful 
parameter if potential interference peak may be of concern. The closest eluting peak to 
the analyte should be selected. 
System Suitability Parameters and Recommendations (ICH Guidelines) 
Parameter                                                             Recommendation  
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Capacity Factor (k’)                   the peak should be well-resolved from other peaks and    
                                                     the void volume, generally k’>2.0  
Repeatability                              RSD </= 1% for N >/= 5 is desirable.  
Relative retention                       not essential as long as the resolution is stated.  
Resolution (Rs)                           Rs of > 2 between the peak of interest and the closest  
                                                    eluting potential interferent (impurity, excipients,   
                                                    degradation product, internal standard, etc). 
Tailing Factor (T)                        T of </= 2  
Theoretical Plates (N)                 In general should be > 2000  
Class A:   Test designed to establish identity, whether of bulk drug substances or   
                 particular ingredient in a finished dosage form. 
Class B:  Method designed to detect and quantitative impurities in a bulk 
drug substance or finished dosage form. 
Class C:  Methods used to determine quantitatively the concentration of a 
bulk drug substance or of a major ingredient in a finished dosage form. 
Class D:  Methods used to assess the characteristics of finished dosage forms 
such as dissolution profile and content uniformity. 
 
Table No: 2 Characteristics that should be considered for different Type of 
analytical procedure:- 
S.No Parameters Class A 
Class B 
Class C Class D Quantitative 
test 
Limit 
test 
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1. Accuracy 
- Yes - Yes Yes 
2. Precision 
- Yes - Yes Yes 
3. Robustness Yes Yes Yes Yes Yes 
4. Linearity and 
Range 
- Yes - Yes Yes 
5. Selectivity Yes Yes Yes Yes Yes 
6. LOD Yes Yes Yes - - 
7. LOQ 
- Yes - - - 
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                          2. LITERATURE REVIEW & DRUG PROFILE 
2.1.LITERATURE REVIEW: 
1.V.Amudhavalli et al22 .,(2001)     have done determination of   Olmesartan and 
hydrochlorothiazide in the pharmaceutical formulation by RP-HPLC.A simple and sensitive 
method was developed on the shimadzu class HPLC system using c18 column. Using mobile 
phase mixture Acetontrile and ammonium acetate buffer(ph-3.5) in the ratio of 55:45.Flow 
rate was 1.0ml/min and the effluents were monitored at 252nm and eluted at 2.14 and 
4.62.The assay was validated for parameters like accuracy, precision, robustness, and 
system suitability. 
2.Sudhakar Nandipati  et al23 .,(2012)  have done Development and validation of RP-
HPLC method for the estimation of Telmisartan in bulk and tablet dosage form .A simple 
RP-HPLC method in the bulk dosage form for estimation of Telmisartan has developed 
.Mobile phase was potassium di-hydrogen phosphate buffer and acetonitrile(60:40) pH 
adjusted with phosphoric acid,c18 sun fire column(250×4.6×5µm) flow rate 1ml/min,wave 
length 243 nm ,column temperature 45˚c,injection volume 10µl.System suitability 
parameters of Telmisartan retention time 3.4,plate count 8968,tailing 1.086,%RSD 0.1 those 
all are within the limit method is suitable for analysis.
 
Validation parameters selectivity, 
precision, linearity, accuracy ,robustness all are within the limit so method was validated it 
is use full to  the pharmaceutical analysis. 
3.Paul Richards M  et al24 .,(2011) have done Simultaneous estimation of Telmisartan and 
Amlodipine Besylate in the pharmaceutical dosage form. The chromatographic analysis was 
performed on ODS symmetry c18 column(150x4.6mm,5µ particle size) with mobile phase 
consisting if acetonitrile and phosphate buffer(ph-4.0) in the ratio of 60:40 v/v,at the flow 
rate of 1.2ml/min and eluents monitored at the 237 nm. The method was validated for 
linearity ,accuracy ,precision ,robustness and application for assay as per the ICH 
guidelines.The retention times of amlodipine besylate and telmisartan were 2.633 and 5.6 
min, respectively.The proposed method is simple, economical, accurate and precise , and 
could be successfully employed in the routine quality control for the simultaneous analysis 
of amlodipine besylate and telmisartan in tablets. 
4.N.J.SHAH et al .,(2012)25 have done Development and validation of a HPTLC method 
for the simultaneous estimation of telmisartan  and hydrochlorothiazide in tablet dosage 
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forms. Its a simple, precise, accurate and rapid high performance thin layer 
chromatographic method has been developed and validated for the estimation of telmisartan 
and hydrochlorothiazide simultaneously in the combined dosage forms. The stationary 
phase used was precoated silica gel 60F254.The mobile phase used was the mixture of 
chloroform :methanol: toluene(2:5:5v/v/v).The detection of the spots was carried out at 272 
nm. The method was validated in the terms of linearity, accuracy, precision and specificity 
.The calibration curve was found to be linear between 250 to 500ng/spot for telmisartan and 
200 to 700 ng/spot for hydrochlorothiazide. The limit of the detection and the limit of 
quantification for the telmisartan were found to be 75 and 190ng/spot, respectively used to 
determine the drug content of the mareted formulation. 
5.Ajit Pandey et al26 .,(2011) have done UV- Spectrophotometric method for estimation of 
telmisartan in the bulk and tablet dosage form .A simple , precise and accurate UV 
spectrophotometric method has been developed and validated for the estimation of 
Telmisartan in the bulk and tablet dosage form. The zero order spectra of Telmisartan in 0.1 
N NaOH shows λmax at 234.0 nm and the estimation was carried out by A(1% 1cm)and by 
comparison with standard. Calibration graph was found to be linear(r2=0.999) over the 
concentration range  4-24µg/ml. The proposed method was validated for its accuracy, 
precision, specificity , ruggedness and  the robustness .The method can be adopted in its 
routine analysis. 
6.R.Vijayamirtharaj et al27 .,(2010) have done Development and validation of  the RP-
HPLC method for the simultaneous estimation of telmisartan and atrovastatin calcium in 
tablet dosage forms. The present research deals with the development of RP-HPLC method 
for the determination of telmisartan and atrovastatin calcium in bulk and formulation using 
uv-detector. Selected mobile phase was a combination of acetoniltrile:buffer(0.001 
potassium dihydrogen phosphate ) 65:35 ph -4.0 (adjusted with orthophosphoric acid) and 
the wavelength selected was 250 nm. The flow rate was kept at 2.0 ml/min, and the 
injection volume was 10µl. Retention times of telmisartan and atrovastatin calcium was 
found to be 3.72 and 6.14 min respectively. Linearity of the method was found to be 319-
480µg/ml for telmisartan and 86-130µg/ml for atrovastatin calcium.This method was 
validated according to ICH guidelines. 
7.Patel Prashant B et al28 .,(2012) have done Second order derivative spectrophotometric 
method for simultaneous the estimation of telmisartan and metoprolol in tablet dosage form 
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.Accurate, precise, rapid and economical method was developed for the estimation of 
telmisartan and metoprolol in bulk and tablet dosage form using second order derivative 
spectrophotometry. Wavelengths selected for quantitation were 299.5nm for telmisartan and 
224nm for the metoprolol. Linearity was observed in the concentration range of 3-15µg/ml 
for both telmisartan and for metoprolol .The accuracy and precision were determined and 
found to comply with ICH guidelines.The proposed method was successfully applied for 
simultaneous estimation of both drugs in the commercial tablet preparation. 
8.Zaveri Maitreyi et al29 .,(2010) have done Development and validation of the RP-HPLC 
for the simultaneous estimation of atenolol and hydrochlorothiazide in the pharmaceutical 
dosage forms. The reverse phase high performance liquid chromatography method of 
atenolol and hydrochlorothiazide is individually available in USP-27 but no reference is 
available for combined estimation of atenelol and hydrochlorothiazide in tablet formulation. 
The aim of our present work was to develop a precise and validated RP-HPLC method for 
simultaneous determination of atenolol and hydrochlorothiazide in tablet formulation.the 
quantification was carried out by using Zorbax SB-CN column in isocratic mode with 
mobile phase, water :buffer: methanol(50:35:15).The flow rate was 1.2ml/min.The pea 
purity of atenolol and hydrochlorothiazide were 0.999 and 1.000 respectively. 
9.Sushant K Shrivastava et al30 .,(2012) have done  Development and validation of a 
HPLC method for simultaneous estimation of amlodipine and telmisartan in the 
pharmaceutical dosage form. The chromatographic separation was achieved by using 
mobile phase acetonitrile and 0.05M sodium dihydrogen phosphate buffer(60:40) adjusted 
to ph-6.0,a c-18 column, perfectsil target ODS3.The mobile phase was pumped a flow rate 
of 0.8ml/min and eluents were monitored at 254nm.Retention times were 4.0 and 8.2 for 
amlodipine and telmisartan respectively. The method was validated in terms of accuracy, 
precision, linearity, range, specificity, limit of detection and limit of quantitation. The 
method was found to be efficient, accurate, precise, specific and economic and is suitable 
for routine quality control analysis. 
10.Rekha Gangola et al31 .,(2011) have done Spectrophotometric simultaneous 
determination of hydrochlorothiazide and telmisartan in  the combined dosage form.Simple 
,sensitive ,specific and economic spectrophotometric method was developed and validated 
for simultaneous quantitation of hydrochlorothiazide and telmisartan in tablet dosage form. 
New method based on the simultaneous estimation of drugs in a binary  mixture without 
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previous separation was developed .In simultaneous equation method ,hydrochlorothiazide 
and telmisartan were quantified using their absorptivity values of at selected wavelengths, 
via., 273 nm and 295 nm respectively. The accuracy and reproducibility of the proposed 
method was statistically validated by recovery studies. The simultaneous equation method 
permits simple, rapid and direct determination of hydrochlorothiazide and telmisartan in 
commercially available tablet dosage form. 
11.Devanand B.Shinde et al32 ., (2011) have done stability indicating LC method for 
simultaneous estimation of Telmisartan and Hydrochlorothiazide in dosage form. A simple 
,rapid and precise method is developed for the quantitative simultaneous estimation of 
Telmisartan and Hydrochlorothiazide  in combined pharmaceutical dosage form. A 
chromatographic separation of the two drugs was achieved with an ACE 5 C18 (250 × 4.6 
mm)analytical column using buffer : acetonitrile (55:45v/v).The buffer used in the mobile 
phase containes 0.1M sodium perchlorate monohydrate in double distilled water and pH 3.0 
was adjusted with trifloro acetic acid .The instrument settings were flow rate 1.5ml/min 
,column temperature at30˚c.The retention times for Hydrochlorothiazide and telmisartan 
were 3.17 and 11.26.The RSD for both drugs were less than 2%.The proposed method was 
found to be suitable and accurate for quantitative determination. 
 12. Joshi Priyanka  et al33 .,(2011) have done Development and validation of reverse phase 
HPLC method for simultaneous of Hydrochlorothiazide  and Telmisartan in tablet dosage 
form.  Present  work  describes  a  simple,  accurate,  precise  and  reproducible  reverse  
phase  High Performance  Liquid Chromatographic method for simultaneous estimation 
of Hydrochlorothiazide and Telmisartan in tablet dosage form on RP C-18 Column ( 
Hypersil Gold, 25cm x 4.6mm, 5µ m) using Acetonitrile and buffer (0.05M  KH2PO4, pH 
3.0±0.02,  35:65 v/v) as mobile phase at a flow  rate  of  1.0  ml/min  and  the  detection  
wavelength  was  225nm.  The  retention  time  for Hydrochlorothiazide  and  Telmisartan  
was  found  to  be  3.71  and  11.72  min.  respectively.  Detection response for both 
Hydrochlorothiazide and Telmisartan were found to be linear  low in concentration 
range  of  6-22.4mcg/ml  and  24.12-56.27mcg/ml  respectively  in  the  linearity   study, 
regression equation and coefficient of correlation for Hydrochlorothiazide and Telmisartan 
were found to be (y = 33409x + 5518, r2 =0.9999) and (y = 111545x – 5850.4, r2 = 
0.9999). Proposed method was validated for accuracy, precision, linearity, range, 
ruggedness & robustness. 
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2.2. DRUG   PROFILE 
 
2.2.1 TELMISARTAN34: 
Molecular  Structure  :  
     
 
N
N
N
N
H3C
H3C
OH
O
CH3
        
                                                              Telmisartan 
 Molecular Formula   :     C33H30N4O2 
 
Chemical Name      :      2-(4-{[4-methyl-6-(1-methyl-1H-1,3-benzodiazol-2-yl)-2-propyl-1H-                 
1,3-benzodiazol-1-yl]methyl}phenyl)benzoic acid 
     
 Molecular Weight  :      514.62 g/mol 
     
 Category                 :      Anti hypertensive agents 
                                             Angiotensin ІІ antagonists 
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Physical Properties of   Telmisartan 
 
Color                          :   White to slight yellowish powder 
Melting Point             :    261-263oC   
State                           :     Solid 
Solubility                   :  Practically insoluble in water ,sparingly soluble in strong acid and      
strong base 
                                                                      
                                          Pharmacological  Properties 
 
Dosage Form                      :         Tablet 
Route of administration    :         Oral 
 
Pharmacology   :  Telmisartan was rapidly absorbed after oral administration in 
Hypertensive  patients. Absolute bioavailability in adults was  42-100% for the tablet. 
Clinical pharmacology: 
Mechanism of Action 35 : Telmisartan interferes with the binding angiotensin ІІ to the 
angiotensin AT1 –receptor by binding reversibly and selectively to the receptors in vascular 
smooth muscle and the adrenal gland.A angiotensin ІІ is a vasoconstrictor ,which also 
stimulates the synthesis and release of aldosterone ,blockage of its effects results in decreases 
in systemic vascular resistance. 
                       Telmisartan acts as a selective modulator of  peroxisome proliferator activated 
receptor-γ ,a regulator of  insulin and glucose metabolism. It is believed that telmisartan’s 
dual mode of action may provide protective benefits against the vascular and renal damage 
caused by diabetis and cardiovascular disease. 
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Absorption and distribution: 
Following oral administration, peak concentrations (Cmax) of telmisartan are reached in 0.5-1 
hour after dosing. Food slightly reduces the bioavailability of telmisartan, with a reduction in 
the area under the plasma concentration-time curve (AUC) of about 6% with the 40 mg tablet 
and about 20% after a 160 mg dose. The absolute bioavailability of telmisartan is dose 
dependent. At 40 and 160 mg the bioavailability was 42% and 58%, respectively. The 
pharmacokinetics of orally administered telmisartan are nonlinear over the dose range 20-160 
mg, with greater than proportional increases of plasma concentrations (Cmax and AUC) with 
increasing doses. Telmisartan shows bi-exponential decay kinetics with a terminal elimination 
half life of approximately 24 hours. Trough plasma concentrations of telmisartan with once 
daily dosing are about 10-25% of peak plasma concentrations. Telmisartan has an 
accumulation index in plasma of 1.5 to 2.0 upon repeated once daily dosing. 
 
                   Telmisartan is highly bound to plasma proteins (>99.5%), mainly albumin and α1 
- acid glycoprotein. Plasma protein binding is constant over the concentration range achieved 
with recommended doses. The volume of distribution for telmisartan is approximately 500 
liters indicating additional tissue binding. 
 
Metabolism and Elimination: 
             Following either intravenous or oral administration of 14C-labeled telmisartan, most 
of the administered dose (>97%) was eliminated unchanged in feces via biliary excretion; 
only minute amounts were found in the urine (0.91% and 0.49% of total radioactivity, 
respectively). 
            Telmisartan is metabolized by conjugation to form a pharmacologically inactive 
acylglucuronide; the glucuronide of the parent compound is the only metabolite that has been 
identified in human plasma and urine. After a single dose, the glucuronide represents 
approximately 11% of the measured radioactivity in plasma. The cytochrome P450 
isoenzymes are not involved in the metabolism of telmisartan. 
         Total plasma clearance of telmisartan is >800 mL/min. Terminal half-life and total 
clearance appear to be independent of dose. 
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Pharmacodynamics 
        In normal volunteers, a dose of telmisartan 80 mg inhibited the pressor response to an 
intravenous infusion of angiotensin II by about 90% at peak plasma concentrations with 
approximately 40% inhibition persisting for 24 hours. 
 
Interactions : 
         Digoxin : When telmisartan was coadministered with digoxin, median increases in 
digoxin peak plasma concentration (49%) and in trough concentration (20%) were observed. 
It is, therefore, recommended that digoxin levels be monitored when initiating, adjusting, and 
discontinuing telmisartan to avoid possible over- or under-digitalization. 
         Warfarin : Telmisartan administered for 10 days slightly decreased the mean warfarin 
trough plasma concentration; this decrease did not result in a change in International 
Normalized Ratio (INR). 
 
Indications:  
      Telmisartan is indicated for the treatment of hypertension. It may be used alone or in 
combination with other antihypertensive agents. 
 
Storage:  
     Store at 25°C (77°F); excursions permitted to 15°-30°C (59°-86°F) [see USP Controlled 
Room Temperature]. Tablets should not be removed from blisters until immediately before 
administration. 
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2.2.2 HYDROCHLOROTHIAZIDE36: 
 Molecular Structure: 
                                       
S
NH
H
N
S
H2N
Cl
OO OO
 
                                                             
                                                        Hydrochlorothiazide 
 
Molecular Formula :   C7H8ClN3O4S2     
Chemical Name        :  6-chloro-1,1-dioxo-3,4-dihydro-2H-1,2,4-benzthiadiazine-7-
sulfonamide                                        
Molecular Weight   :       297.74 g/mol   
Category                   :     Thiazide diuretic 
                                         Anti hypertensive agent 
                                       Na-Cl symporter inhibitors 
                                         
                                  
    
 
Physical Properties of Hydrochlorothiazide 
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Color                         :   White to half white crystalline powder 
Melting Point           :     273-275oC 
State                          :    Solid   
Solubility                  :   Soluble in dilute ammonia and NaOH ,also soluble in methanol,       
acetone, ethanol .  Freely soluble in NaOH  ,n-butylamine , dimethylformamide. 
                                             Pharmacological  Properties 
 
Dosage Form                      :         Tablet 
Route of administration    :         Oral 
 
Pharmacology  :Hydrochlorothiazide variably absorbed from GI tract.Bioavailability  of 
drug is 70%.Does not undergo significant metabolism(>95% of drug unchanged in urine) 
Clinical pharmacology: 
Mechanism of Action37,38 :   Hydrochlorothiazide, is a thiazide diuretic, inhibits water 
reabsorption in the nephron by inhibiting the  Na-Cl Symporter  in the distal convoluted 
tubule, which was responcible for 5% of  sodium reabsorption. Normally, the Na-Cl  
symporter transports Na and Cl from the lumen into the epithelial cell lining  distal 
convoluted tubule. The energy for this is provided by a Na gradient established by Na-k 
ATPases on the basolateral membrane. Once Na was entered in the cell, it is transported out 
in the basolateral interstitium via  Na-k ATPase, causing an increase in the osmolarity of the 
interstitium, there by establishing an osmatic gradient for water reabsorption. By blocking the 
Na-Cl symporter, hydrochlorothiazide effectively  reduces the osmatic gradient and water 
reabsorption throughtout the nephron.Hydrochlorothiazide, a thiazide diuretic, inhibits water 
reabsorption in the nephron by inhibiting the Na-Cl  in the distal convoluted , which is 
responsible for 5% of total sodium reabsorption. Normally, the Na-Cl symporter transports 
Na and Cl from the lumen in the epithelial cell lining the distal convoluted tubule. The energy 
for this is provided by a Na gradient established by Na-K ATPases on the basolateral 
membrane. Once Na has entered the cell, it is transported out into the basolateral interstitium 
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via the Na-k ATPase, causing an increase in the osmolarity of the interstitium, thereby 
establishing an osmotic gradient for water reabsorption. By blocking the sodium-chloride 
symporter, hydrochlorothiazide effectively reduces the osmotic gradient and water 
reabsorption throughout the nephron. 
Pharmacodynamics: 
     In normal volunteers, a dose of Hydrochlorothiazide 25 mg inhibited the pressor response 
to an intravenous infusion of angiotensin II by about 90% at peak plasma concentrations with 
approximately 40% inhibition persisting for 24 hours. 
Indications and Usage : 
       Hydrochlorothiazide tablets are indicated as adjunctive therapy in edema associated with 
congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. 
        Hydrochlorothiazide tablets have also been found useful in edema due to various forms 
of renal dysfunction such as nephrotic syndrome, acute glomerulonephritis, and chronic renal 
failure. 
        Hydrochlorothiazide tablets are indicated in the management of hypertension either as 
the sole therapeutic agent or to enhance the effectiveness of other antihypertensive drugs in 
the more severe forms of hypertension. 
Drug Interactions: 
         When given concurrently the following drugs may interact with thiazide diuretics. 
Alcohol, barbiturates, or narcotics—potentiation of orthostatic hypotension may 
occur.Antidiabetic drugs (oral agents and insulin)—dosage adjustment of the antidiabetic 
drug   may be required. Other antihypertensive drugs—additive effect or potentiation. 
 
 
 
 
 
Chapter: 2                                                                           Literature Review & DrugProfile    
 
RVS College of Pharmaceutical Sciences, Coimbatore Page 42 
 
 
 
 
 
 
Chapter: 3                                                                                          Aim and Plan of work      
 
RVS College of Pharmaceutical Sciences, Coimbatore  Page 42 
 
                                   3. AIM AND PLAN OF WORK 
 AIM : 
 
 Telmisartan is a angiotensin-ІІ inhibitor. It is used in the treatment of hypertension. 
Hydrochlorothiazide is a thiazide diuretic. It is also used in the treatment of hypertension. 
The combination of these two drugs used  effectively in the treatment of hypertension in 
combined dosage form.  
 Literature survey reveals that Telmisartan and Hydrochlorothiazide is estimated 
individually and simultaneously by UV, derivative – HPLC, Plasma RP-HPLC and 
Plasma LC/MS/MS methods. Few RP-HPLC methods were reported for estimation of 
Telmisartan, Ramipril and  amlodipine in pharmaceutical formulation. 
 
 RP-HPLC, LC-MS/MS and HPTLC methods were reported for the simultaneous 
estimation of Metoprolol and hydrochlorothiazide in human plasma and in formulations.  
Also UV, HPLC, LC–MS, HPTLC and enzymatic assay methods were reported for the 
simultaneous estimation of Telmisartan with other anti-hypertensive drugs . 
 
 Thus, efforts were made to develop economical  and sensitive analytical method for 
Simultaneous estimation of Telmisartan and Hydrochlorothiazide in their combined 
dosage form. 
Plan of work : 
The plan of the proposed work includes the following steps: 
• The extensive survey of literature for Telmisartan and Hydrochlorothiazide regarding 
their physico-chemical properties and analytical methods. This forms the basis for the 
development of methods. 
• Selection of suitable solvent for quantitative extraction of analyte present in the 
formulations. The solvent should be readily available, economical and of analytical 
grade. 
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• To develop initial chromatographic conditions by selection of suitable column and 
appropriate wavelength in UV for detection and optimization of the method. 
• To validate analytical method developed as per the ICH Q2B guidelines.  
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                                        4.  EXPERIMENTAL PART   
 
4.1 MATERIALS AND INSTRUMENTS 
4.1.1 Instruments:  
     Table No 3: Table showing list of the Instruments used 
 
S. No 
 
 
Name of the 
Instrument 
 
Make 
 
Model 
 
  1. 
 
 
       HPLC 
 
   Water 
 
   Alliance-2695 
  PDA Waters-2996 
 
 
2. 
 
 
Electronic balance 
 
Shimadzu 
 
  AY 220 
 
3. 
 
 
Digital pH
 
meter 
 
Digisun Electronics 
 
   7007 
 
4. 
  
Centrifuge 
 
Thermolab 
 
  R8C 
 
5. 
  
PhotoStability 
Chamber 
 
 Thermolab 
 
943/03/0607 
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4.1.2 Reagents and chemicals: 
                                 Table No 4: Table showing list of the chemicals used 
 
S. No 
 
Name 
 
Grade 
 
 
Manufacturer/ 
Supplier 
 
    
   1. 
 
Telmisartan and 
Hydrochlorothiazide working 
standard 
 
                - 
   
 
 
  2. 
 
         Acetonitrile 
 
 
           HPLC 
 
     Merck 
 
  3. 
     
Trifluoro acetic acid 
 
 
 
          HPLC 
 
     Merck 
  
 4. 
       
       Methanol 
 
 
          HPLC 
 
     Merck 
  
 5. 
 
 
        Water 
 
             - 
 
         - 
 
 6. 
 
   
Milli Q Water 
 
        HPLC 
       
         - 
 
7. 
 
Potassium dihydrogen phosphate 
buffer 
 
        HPLC 
 
          - 
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4.2 METHOD  DEVELOPMENT  AND  OPTIMIZATION OF TELMISARTAN 
AND  HYDROCHLOROTHIZIDE 
1. SELECTION  OF  DETECTOR  WAVELENGTH:  
The wave length selection is made at 271 nm since all the two compounds maximum 
absorbance in UV spectrum as reported in the literature is in 271 nm.  
4.2.2 OPTIMIZED CHROMATOGRAPHIC CONDITIONS: 
a. Selection of Stationary phase: 
 As the drugs were polar in nature, non- polar stationary phase was preffered.The 
hypersil BDS column was selected as reported in the literature. 
b.Selection of mobile phase:  
           The hydrochlorothiazide soluble in acetonitrile,methanol,water.But Telmisartan 
only soluble in 50:50 acetonitrile and methanol.So the buffer  methanol and acetonitrile 
were selected  as starting mobile phases.The starting buffer was potassium dihydrogen 
phosphate buffer because the pH of this buffer is related to pka  values of both drugs. 
              
b.Procedure: 
  Preparation of mobile phase: 
  About 3.2 g of potassium dihydrogen phosphate was weighed and dissolved in 
1000 ml water.The  pH was adjusted  to 3.4 with ortho phosphoric acid.500 ml of this 
buffer solution was added to 250 ml of acetonitrile and to this the 250 ml of methanol 
was added to produse 1000 ml. Mobile phase  buffer : acetonitrilr:methanol(50:25:25).
 
Preparation of Standard Solution: 
                  Accurately 80 mg of Telmisartan and 25 mg of Hydrochlorothiazide  were 
weighed and transferred into 100ml volumetric flask, about 70ml of diluent was added 
and sonicated for 5 minutes to dissolve it. The volume was made up with mobile phase. 
The solution was filtered through 0.45µm membrane filter (Stock solution). 
                 From this 5 ml of solution was pipette out and transferred into 50ml of 
volumetric flask and the volume was made up with mobile phase. The solution was 
filtered through 0.45µm membrane filter.Inject 20 µl of the standard solution into the 
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chromatographic system and measure the area for the Telmisartan and 
Hydrochlorothiazide peaks and calculate the %Assay by using the assay formula.  
 
4.3 .TRIAL&ERROR METHODS:  
TRIAL- 1: 
CHROMATOGRAPHIC CONDITIONS: 
Column                         : Hypersil BDS (4.6 x 150mm, 5 µm, Make: ACE) 
Detector                        : 271nm 
Flow rate                      : 1ml/min 
Injection volume          : 20µl 
Run time                      : 10min 
Mobile phase               : Buffer (phosphate buffer): Methanol:ACN (50:25:25)  
PH                                :3.4 
 
Results of Trial-1: Telmisartan Peak was not sharp.USP plate count was recorded as 889.Due 
to asymmetry in peaks,identification of interferences and USP plate count not meet the 
acceptance criteria . so reduce RT’s another trial is made with change in mobile phase-buffer pH 
and flow rate. 
Fig No: 4.1 
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TRIAL-2:   
CHROMATOGRAPHIC CONDITIONS: 
Column                         : Hypersil BDS (4.6 x 150mm, 5 µm, Make: ACE) 
Detector                        : 271nm 
Flow rate                       : 1.2ml/min 
Injection volume            : 20µl 
Run time                        : 10min 
Column temperature      : 30°c 
 Mobile phase               : Buffer (PHOSPHATE BUFFER): ACN (50:50)  
PH                                                  : 3.4 
 
Results of Trial-2: Retention time observed at  3.109 and 12.359. Due to asymmetry in 
peaks another trail is made inorder to reduce RT’s with change in mobile phase.  
Fig No: 4.2 
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TRIAL-3: 
CHROMATOGRAPHIC CONDITIONS: 
Column                         : Hypersil BDS (4.6 x 150mm, 5 µm, Make: ACE) 
Detector                        : 271nm 
Flow rate                       : 0.8ml/min 
Injection volume            : 20µl  
Run time                        : 10min 
Column temperature      :  30°c 
 Mobile phase               : Buffer (Ammonium dihydrogen phosphate buffer): ACN 
                                       (50:50) 
 
Results of Trial-3: RT’s were observed at 3.114(Hydrochlorothiazide) and 
11.915(Telmisartan). Inorder to reduse the RT’S another trial is made with change in 
mobile phase. 
 
FIG:4.3 
 
TRIAL-4 
CHROMTOGRAPHIC CONDITIONS: 
Column                                 :   Symmetry C18 (INERTSIL ODS 150x4.6mm) 
Detector                             :    271 
Flow rate                            :  1ml/min 
Injection volume                 :   20µl 
Run time                            :  12 min 
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Column temperature            : 25˚C 
Mobile phase                      :Trifluoro acetic acid:ACN(70:30) 
 
  Preparation of mobile phase: 
Mix a mixture of above buffer 700mL (70%) and 300 mL of ACN  (30%) and degas in 
ultrasonic water bath for 5 minutes. Filter through 0.45 µ filter under vaccum filtration.  
Results of Trial-4  :Retention times were observed at 2.788(Hydrochlorothiazide) and 
9.813(Telmisartan).The peaks were sharp with less tailing and USP plate count meet the 
acceptance criteria and RT’S were reduced .Hence the trial-4 is optimized for analysis. 
FIG:4.4 
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4.4. ANALYTICAL METHOD-OPTIMISATION 
Aim: The present study is to develop a new reverse phase liquid chromatographic 
method for simultaneous determination of Telmisartan and Hydrochlorothiazide  in tablet 
dosage form.  
Table No : 5 Table showing Optimized Chromatographic Parameters 
OPTIMIZED CHROMATOGRAPHIC CONDITIONS 
      
Mode of separation 
 
isocratic elution 
Mobile phase Solvent-A: Trifluoro acetic acid  pH-3 
Solvent-B: Acetonitrile(70:30) 
Column 
 INERTSIL ODS(4.6 x 150mm, 5 µm) 
Flow rate 
1 mL/ min 
Detection  Wavelength 
271 nm 
Injection volume 
20 µl 
Column oven temperature Ambient(25°C) 
Run time 12 min 
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Fig No: 4.5  Chromatogram showing peaks of standard solution of  
 Telmisartan and Hydrochlorothiazide 
 
 
 
4.5 QUANTITATIVE DETERMINATION OF THE DRUG BY USING THE 
DEVELOPED METHOD 
Sample :  Telmisartan and Hydrochlorothiazide 
Label claim : 40mg,12.5mg 
 Standard Solution Telmisartan and  Hydrochlorothiazide: 
                  Accurately 80 mg of Telmisartan and  25mg of Hydrochlorothiazide were 
weighed and transferred into 100ml volumetric flask, about 70ml of diluent was added 
and sonicated for 5 minutes to dissolve it. The volume was made up with mobile phase. 
The solution was filtered through 0.45µm membrane filter (Stock solution). 
                 From this 5ml of solution was pipette out and transferred into 50ml of 
volumetric flask and the volume was made up with mobile phase. The solution was 
filtered through 0.45µm membrane filter. 
             Inject 20 µl of the standard solution into the chromatographic system and measure 
the area for the Telmisartan and  Hydrochlorothiazide peaks and calculate the %Assay by 
using the assay formula.  
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 Sample Solution Telmisartan  and Hydrochlorothiazide:  
                          20 Telmisartan and Hydrochlorothiazide tablets were weighed and the 
average weight was calculated. Accurately the sample equivalent to 80 mg of 
Telmisartan &25 mg of Hydrochlorothiazide was weighed & transferred into 100ml 
volumetric flask about 70ml of diluent was added and sonicated for 5 minutes to dissolve 
it content. The volume was made up with mobile phase. The solution was filtered 
through 0.45µm membrane filter (stock solution). 
              5ml of stock solution was pipetted out and transferred into 50ml of volumetric 
flask and the volume was made up with mobile phase. The solution was filtered through 
0.45µm membrane filter. 
 
 
Assay formula: 
                    AT               WS           DT                          
 --------------- x ----------x --------- x average weight of tablet 
           AS              DS           WT                   
Where,   
 AT = Peak Area of sample solution. 
 AS = Peak Area of standard solution. 
 WS = Weight of working standard taken in mg 
 WT = Weight of sample taken in mg  
 DS = Dilution of Standard solution  
 DT = Dilution of sample solution 
          
Acceptance criteria: The limit of assay is in between the 98% - 102% 
The chromatograms are as shown in Fig No: 4.6 & 4.7  and assay results are tabulated 
and are as shown in Table No: 6 
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Chromatogram showing peaks of standard solution of Telmisartan  and 
Hydrochlorothiazide. 
 Fig No :4.6 
 
 
 
 
 
Chromatogram showing peaks of test solution of Telmisartan and  
Hydrochlorothiazide. 
Fig No : 4.7 
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Table  showing Assay Results of Telmisartan  and Hydrochlorothiazide: 
Table No: 6 
 
S. No Compound name Assay value 
1. Telmisartan 99.56% 
2. Hydrochlorothiazide 99.1% 
 
 4.6. VALIDATION  
Definition: Validation is a process of establishing documented evidence which provides a 
high degree of assurance that a specific process will consistently produce meeting, its 
predetermined specifications and quality attributes. 
The objective of the analytical procedure should be clearly understood since this will 
govern the validation characteristics which need to be evaluated. Typical validation 
characteristics which should be considered are listed below. 
• Accuracy  
• Precision  
• Specificity 
• Linearity & Range 
• Robustness 
• Ruggedness 
• System suitability testing  
 
After method development, the validation of the current method has been performed in 
accordance with USP requirements for assay determination (Category-I: analytical 
methods for quantitation of active ingredients in finished pharmaceutical products) which 
include accuracy, precision, selectivity, linearity and range, robustness and ruggedness. 
 4.6.1   SYSTEM SUITABILITY TESTING 
 
System suitability testing is an integral part of many analytical procedures. The 
tests are based on the concept that the equipment, electronics, analytical operations and 
samples to be analyzed constitute an integral system that can be evaluated as such. 
System suitability test parameters to be established for a particular procedure depend on 
the type of procedure being validated and the parameters like tailing factor, retention 
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time, theoretical plates per unit, resolution factor are determined and the results are 
tabulated and are as shown in Table No: 7 
 
Method 
Preparation of Standard solution: 
Standard Solution Telmisartan and  Hydrochlorothiazide: 
                  Accurately 80 mg of Telmisartan and 25 mg of Hydrochlorothiazide were 
weighed separately and transferred into two 100ml volumetric flasks, about 70ml of 
diluent (ACN:MET)was added to two flasks and sonicated for 5 minutes to dissolve it. 
The volume was made up with mobile phase. The solutions were filtered through 0.45µm 
membrane filter (Stock solutions). 
                 From above solutions 5 ml Telmisartan stock solution and 5ml of 
Hydrochlorothiazide  were  pipetted out  and  transferred  into  50 ml of volumetric flask 
and the volume was made up with mobile phase. The solution was filtered through 
0.45µm membrane filter. 
             Inject 20 µl of the standard solution into the chromatographic system and measure 
the area for the Telmisartan and  Hydrochlorothiazide peaks and calculate the %Assay by 
using the assay formula.  
  
               
             Acceptance criteria: 
a. The column efficiency is not less than 2000 theoretical plates. 
b. The tailing factor for the analyte peak is not more then 2.0. 
c. The relative standard deviation for the replicate injections more than 2.0%.  
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Chromatograms  showing system suitability testing of Standard Solutions of 
Telmisartan and  Hydrochlorothiazide. 
Fig No : 4.8 
 
Fig No : 4.9 
 
Fig NO:4.10 
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Fig NO :4.11 
 
Fig No: 4.12 
 
Fig No : 4.13 
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Table showing list of system suitability parameters of Telmisartan and 
Hydrochlorothiazide. 
 
Table No : 7 
 
Parameters Telmisartan Hydrochlorothiazide 
Tailing factor 1.5 1.6 
Retention time 2.778 9.831 
Theoretical plates per unit 2766.24 2853.19 
 
 
   
4.6.2  ACCURACY 
The accuracy of an analytical method is the closeness of that results obtained by 
that method to the true value. Accuracy may often be expressed as percent recovery by 
the assay of known added amount of analyte. 
Determination: 
The accuracy of the analytical method was determined by applying the method to 
the analyzed samples, to which known amounts of analyte had been added. The accuracy 
was calculated from the test results as the percentage of analyte recovered by the assay. 
Procedure: 
Preparation of Standard solution :     
                  Accurately 80 mg of Telmisartan and 25 mg Hydrochlorothiazide were 
weighed separately  and transferred into two 100ml volumetric flasks, about 70ml of 
diluent was added to each flask and sonicated for 5 minutes to dissolve it. The volume 
was made up with mobile phase. The solutions was filtered through 0.45µm membrane 
filter (Stock solutions). 
                 From these above solutions 5ml  of  Telmisartan and 5 ml of 
Hydrochlorothiazide stock solutions was pipetted out and transferred into 50ml of 
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volumetric flask  and the volume was made up with mobile phase. The solution was 
filtered through 0.45µm membrane filter. 
Preparation of 50% sample solution(40µg/ml Telmisartan and 12.5µg/ml 
Hydrochlorothiazide): 
                Accurately weighed quantity of placebo and transferred into two 100 ml 
flasks.To this flask accurately weighed quantity of  40 mg of Telmisartan and 12.5 mg of 
Hydrochlorothiazide were weighed separately and transferred into two 100ml volumetric 
flasks, about 70ml of diluent was added to each flask and sonicated for 5 minutes to 
dissolve it. The volume was made up with mobile phase. The solution was filtered 
through 0.45µm membrane filter (Stock solutions). 
     From these above solutions 5ml  of Telmisartan and 5ml of Hydrochlorothiazide 
solutions were pipetted out and transferred into 50ml of volumetric flask and the volume 
was made up with mobile phase. The solution was filtered through 0.45µm membrane 
filter. 
 Preparation of 100% solution(80µg/ml Telmisartan and 25µg/ml 
Hydrochlorothiazide):                 
                  Accurately weighed quantity of placebo transferred into two 100 ml flasks.To 
this  80 mg of Telmisartan  and 25 mg Hydrochlorothiazide were weighed separately  and 
transferred into two 100ml volumetric flasks, about 70ml of diluent was added to each 
flask and sonicated for 5 minutes to dissolve it. The volume was made up with mobile 
phase. The solutions was filtered through 0.45µm membrane filter (Stock solutions).                         
                     From these above solutions 5ml  of Telmisartan and 5ml of 
Hydrochlorothiazide solutions were pipetted out and transferred into 50ml of volumetric 
flask and the volume was made up with mobile phase. The solution was filtered through 
0.45µm membrane filter. 
Preparation of 150% solution(120 µg/ml Telmisartan and 37.5µg/ml 
Hydrochlorothiazide):               
                   Accurately weighed quantity of placebo transferred into two 100 ml flasks.To 
this accurately weighed quantity of  120 mg of Telmisartan & 37.5 mg 
Hydrochlorothiazide were weighed separately  and transferred into two 100ml volumetric 
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flasks, about 70ml of diluent was added to each flask and sonicated for 5 minutes to 
dissolve it. The volume was made up with mobile phase. The solutions was filtered 
through 0.45µm membrane filter (Stock solutions).                         
                      From these above solutions 5ml of Telmisartan and 5ml of 
Hydrochlorothiazide solutions were pipetted out and transferred into 50ml of volumetric 
flask and the volume was made up with mobile phase. The solution was filtered through 
0.45µm membrane filter.                       
                    Inject 20µl of placebo and standard solutions of Accuracy -50%, Accuracy -
100% and Accuracy -150% solutions 3 times into HPLC. Now calculate the amount 
obtained and amount added (API) for Telmisartan  and  Hydrochlorothiazide   samples.  
 
Calculate the concentration in µg/ml in the spiked placebo in all the above cases by 
comparing with the standard solution. Calculate the individual recovery and mean 
recovery values. The chromatograms are as shown in Fig. No: 4.14 to 4.22 and the results 
are tabulated and shown in Table No: 8 
 
Formula:                                              (Amount recovered)   
                         %recovery     =                                                  × 100 
                                                           (Actual amount added) 
Acceptance criteria: 
Percentage recovery in all the cases should be between 98.0 and 102.0 %. 
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Chromatograms showing Accuracy 50% of  Telmisartan and  Hydrochlorothiazide. 
Fig No : 4.14 
 
Fig NO:  4.15 
Fig NO :4.16 
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Chromatograms  showing Accuracy -100% of Telmisartan and 
Hydrochlorothiazide.           
Fig No :4.17 
 
FigNO:4.18 
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Fig NO:4.19 
 
Chromatogram  showing Accuracy – 150% of Telmisartan and 
Hydrochlorothiazide. 
          Fig No : 4.20 
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FigNO: 4.21 
 
 
 
FigNO:4.21 
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 Table showing results of % Recovery studies for Telmisartan and 
Hydrochlorothiazide. 
Table No : 8 
 
 
 
 
 
 
 
 
Inj. 
Sample 
Spike 
level 
Average 
area of 3 
injection
s 
 
%RS
D 
 Amount  
Amoun
t 
recover
ed 
%  
recovere
d 
Mean 
recover
y 
Accepta
nce 
Criteria 
Telmis
artan 
50 % 
 
238018
1 
 
0.45 
                 
40µg 
39.94µ
g 
99.85% 
 
99.85
% 
 
 
 
98-
102% 
100 
% 
 
799069
7 
 
0.35 
                    
80µg 
79.96µ
g 
99.95% 
150 
% 
 
101109
23 
 
0.33 
                 
120µg 
119.73
µg 
99.77% 
Hydroc
hloroth
iazide 
50 % 
 
924988 
 
0.57 
                 
12.5µg 
12.27µ
g 
98.16% 
98.62
%.5 
 
 
 
98-
102% 
100 
% 
 
301788
4 
 
0.27 
                   
25µg 
24.91µ
g 
99.64% 
150 
% 
 
399281
6 
 
0.45 
                  
32.5µg 
31.87µ
g 
98.06% 
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4.6.3.  PRECISION 
Precision of an analytical method is the degree of agreement among individual 
test results when the procedure is applied repeatedly to multiple sampling of a 
homogenous sample. Precision of analytical method is usually expressed as the standard 
deviation and relative standard deviation. 
Determination: 
The precision of the analytical method was determined by assaying sufficient 
number of samples and relative standard deviation was calculated. 
The precision of the instrument was determined by assaying the samples 
consecutively, number of time and relative standard deviation was calculated. 
Procedure: 
A) System Precision: 
Preparation of Standard Solution :                
   Accurately 80 mg of Telmisartan and 25 mg of Hydrochlorothiazide were weighed 
separately and transferred into two 100ml volumetric flasks, about 70ml of diluent 
(ACN:MET)was added to two flasks and sonicated for 5 minutes to dissolve it. The 
volume was made up with mobile phase. The solutions were filtered through 0.45µm 
membrane filter (Stock solutions). 
                  From above solutions 5ml Telmisartan stock solution and 5ml of 
Hydrochlorothiazide  were  pipetted out  and  transferred  into  50 ml of volumetric flask 
and the volume was made up with mobile phase. The solution was filtered through 
0.45µm membrane filter. 
             Inject 20µl of the blank solution  and the standard  solution  of  for five times and 
calculate the %RSD  for  the  area of six  replicate  injections.The chromatograms  are as  
shown in Fig No: 4.23-4.29  and the results are tabulated shown in Table No:9. 
 
Blank solution: Mixture of trifluoro acetic acid (pH3) and  acetonitrile  in ratio of 70:30 was 
filtered and degassed. 
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System Precision: 
Chromatogram showing Precision-blank solution.  
Fig No : 4.23 
 
 Chromatograms showing System  Precision of  Standard  for Telmisartan and 
Hydrochlorothiazide           
Fig No : 4.24 
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Fig No : 4.25   
   Fig No : 4.26 
         
    
  Fig No :4.27             
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Fig No :4.28 
   
           
Fig No : 4.29 
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B) Method Precision: 
 
Preparation of Sample Solution:  
                              Accurately pipette out 5ml of the sample (equivalent to 0.8µg/ml of 
Telmisartan &0.25µg/ml of Hydrochlorothiazide) into a 50 ml volumetric flask  and 
made up to the mark with mobile phase. Mix well and filter through 0.45µm filter.  
                  Inject 50µl of the blank solution and six replicate injections of sample solution of 
100 µg/ml for six times and calculate the %RSD for the area of six replicate injections.  
 
      %RSD Formula:  (σ /µ)*100 
 
 
Acceptance criteria: % Relative standard deviation (%RSD) for the areas of Telmisartan 
& Hydrochlorothiazide from the standard chromatograms should not be more than 2.0  
       The method precision was determined by preparing the sample from the tablet 
formulation for five times and six successive injections of 20µl of working sample 
solution were injected and the chromatograms were recorded and shown in Fig No:4.30 
to 4.35  and method precision data are shown in table. 9 
Chromatogram showing Method Precision of Telmisartan and  
Hydrochlorothiazide 
Fig No : 4.30 
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FigNO:4.31 
    
 
 
FigNO:4.32 
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FigNO:4.33 
 
 
FigNO:4.34 
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FigNO:4.35 
 
 
Table showing Results of Precision for Telmisartan and  Hydrochlorothiazide 
Table No : 9 
 
 
 
 
 
 
 
 
Parameter Method Precision System Precision 
Average 
Area 
Telmisartan Hydrochlorothiazide Telmisartan Hydrochlorothiazide 
8025108 3032192 8003386 3019442 
SD 32150.46 12121.06 25110.58 9173.278 
%RSD 0.4 0.3 0.31 0.3 
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4.6.4. SPECIFICITY: 
             Specificity is the ability to assess unequivocally the analyte in the presence of 
components which may be expected to be present. Typically these might include 
impurities, degradants, matrix, etc. 
 
Procedure: 
Preparation of placebo :  
 Placebo was prepared by mixing all the excipients without active ingredients. 
                 Accurately 195 mg of placebo was weighed and transferred into 100ml 
volumetric flask, about 70ml of diluent was added and sonicated for 5 minutes to 
dissolve it. The volume was made up with mobile phase. The solution was filtered 
through 0.45µm membrane filter (Stock solution). 
                 From this 5ml of solution was pipetted out and transferred into 50ml of 
volumetric flask and the volume was made up with mobile phase. The solution was 
filtered through 0.45µm membrane filter. 
        Inject 20 µl of placebo solution  into the HPLC system and chromatograph. 
Compare the chromatograms visually and check for any interference. 
 
Preparation of Standard solution :                  
            Accurately 80 mg of Telmisartan and 25 mg of Hydrochlorothiazide were 
weighed separately and transferred into two 100ml volumetric flasks, about 70ml of 
diluent (ACN:MET)was added to two flasks and sonicated for 5 minutes to dissolve it. 
The volume was made up with mobile phase. The solutions were filtered through 0.45µm 
membrane filter (Stock solutions). 
                 From above solutions  5 ml Telmisartan stock solution and 5ml of 
Hydrochlorothiazide  were  pipetted out  and  transferred  into  50 ml of volumetric flask 
and the volume was made up with mobile phase. The solution was filtered through 
0.45µm membrane filter. 
         Inject 20 µl of Standard solution for six times into the HPLC system and 
chromatograph. 
Compare the chromatograms visually and check for any interference. 
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Preparation of Standard + placebo:  
                 Accurately weighed quantity of placebo transferred into two 100 ml flasks. To 
this  accurately weighed quantity of  80 mg of Telmisartan and 25 mg of 
Hydrochlorothiazide weighed separately and transferred into flasks.   To this  about 70 
ml of diluents was added and sonicated for 5 minutes to dissolve it. The volume was 
made up with mobile phase. The solution was filtered through 0.45µm membrane filter 
(Stock solution). 
                 From this 5 ml  of solution was pipette out and transferred into 50 ml of 
volumetric flask and the volume was made up with mobile phase. The solution was 
filtered through 0.45µm membrane filter. 
        Inject 20 µl of Standard solution for six times into the HPLC system and 
chromatograph. 
Compare the chromatograms visually and check for any interference. 
    
    %RSD Formula:  (σ /µ)*100 
Acceptance criteria: 
 There should not be any peak in the blank and Placebo solution run at the retention time 
corresponding to Telmisartan and  Hydrochlorothiazide as in standard run. 
 
Chromatogram showing Specificity- Blank solution  
Fig No : 4.36 
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Chromatogram showing Specificity-Standard  solution of  Telmisartan and 
Hydrochlorothiazide.   
    Fig No : 4.37 
 
Chromatogram showing   placebo+standard solution  
Fig No : 4.38 
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4.6.5. LINEARITY&RANGE 
  
LINEARITY:  Linearity is the ability of the method to obtain test results that are directly 
proportional to the analyte concentration within a given range. 
 Range: Range of analytical procedure is the interval between the upper and lower 
concentration of analyte in the sample (including concentrations) for which it has been 
demonstrated that the analytical procedure has a sutable level of precision, accuracy, and 
linearity. 
Procedure:  
Preparation of Standard Stock Solution:  
                 Accurately 80 mg of Telmisartan and 25 mg of Hydrochlorothiazide were 
weighed separately and transferred into two 100ml volumetric flasks, about 70ml of 
diluent was added and sonicated for 5 minutes to dissolve it. The volume was made up 
with mobile phase. The solution was filtered through 0.45µm membrane filter (Stock 
solution). 
Preparation of  sample solutions:  
 From the above stock solution pipette out 0.5, 1, 2.5, 5.0,6.0 and7.5ml 
respectively into individual 50ml of volumetric flasks and diluted up to the mark with 
diluent to prepare 10,20,50,100,120,150% sample solutions respectively. Mix well and 
filter through 0.45µm filter.       
 Inject 20µl of blank solution and each linearity level standard solutions into the 
chromatographic system and measure the peak area. Plot a graph of peak area versus 
concentration (on X-axis concentration and on Y-axis Peak area) and calculate the 
correlation coefficient. The results are tabulated shown in Table No: 11 
                          
 
   Acceptance criteria for Range: 
 Correlation coefficient should not be less than 0.99% 
 The linearity data and analytical performance parameters of are shown in table and 
calibration curve of is shown Fig No: 4.39 to 4.44.  
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Chromatogram  showing Linearity level-1 (10%) Telmisartan and 
Hydrochlorothiazide 
Fig No : 4.39 
 
 
Chromatogram showing Linearity level-2 (20%) of  Telmisartan and 
Hydrochlorothiazide 
Fig No: 4.40 
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Chromatogram showing Linearity level-3 (50%) of  Telmisartan and 
Hydrochlorothiazide. 
Fig No : 4.41 
 
 
Chromatogram showing Linearity level-4 (100%) of Telmisartan and 
Hydrochlorothiazide. 
Fig No : 4.42 
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 Chromatogram showing Linearity level-5 (120%) of Telmisartan and 
Hydrochlorothiazide. 
Fig No : 4.43 
 
 
Chromatogram showing Linearity level-6 (150%) of Telmisartan and 
Hydrochlorothiazide. 
FigNO:4.44 
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Linearity Results (for Telmisartan): 
Table No : 10 
S. No Linearity Level Concentration Area 
1 I 8µg/ml 779093 
2 II 16µg/ml 1659459 
3 III 40µg/ml 4005821 
4 IV 80µg/ml 8011642 
5 V 96µg/ml 9613970 
6 VІ 120µg/ml 11817460 
Correlation Coefficient 0.9998 
 
Figure showing Linearity graph of Telmisartan. 
FigNO:4.45 
 
 
 
 
 
 The correlation coefficient value was found to be 0.999 
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Linearity Results for Hydrochlorothiazide: 
Table No : 11 
S. No Linearity Level Concentration Area 
1 I 2.5µg/ml 301937 
2 II 5.0µg/ml 620422 
3 III 12.5µg/ml 1512794 
4 IV 25µg/ml 3025588 
5 V 30µg/ml 3630705 
6 VІ 37.5µg/ml 4438382 
Correlation Coefficient 0.9996 
 
 Figure showing linearity graph of Hydrochlorothiazide. 
Fig No : 4.46 
 
 
The correlation coefficient value was found to be 0.9996 
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4.6.6 ROBUSTNESS 
 
  It is a measure of ability to remain unaffected by small but deliberate variations in 
method parameters and provides an indication of its reliability during normal usage. 
          The robustness of an analytical method was determined by analysis of aliquots 
from homogenous lots by differing physical parameters that may differ but were still 
within the specified parameters of the assay for example change in physical parameters 
like flow rate, column temperature and mobile phase ratio. 
 
Preparation of Standard Solution :           
             Accurately 80 mg of Telmisartan and  25 mg of Hydrochlorothiazide were 
weighed separately and transferred into two 100ml volumetric flasks, about 70ml of 
diluent (Acetonitrile:Methanol)was added to two flasks and sonicated for 5 minutes to 
dissolve it. The volume was made up with mobile phase. The solutions were filtered 
through 0.45µm membrane filter (Stock solutions). 
                  From above solutions 5 ml Telmisartan stock solution and 5ml of 
Hydrochlorothiazide  were  pipetted out  and  transferred  into  50 ml of volumetric flask 
and the volume was made up with mobile phase. The solution was filtered through 
0.45µm membrane filter. 
 
         Inject 20µl of the blank solution and the standard solution  for five times and 
analysed using varied flow rates (1.2ml, 0.8 ml) along with method flow rate and 
calculate the %RSD for the area of five replicate injections.  
 
a) The flow rate was varied at ±0.2 ml/min. 
%RSD of Telmisartan  and Hydrochlorothiazide  assay under these conditions is 
calculated and the results are shown in below. 
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PROCEDURE 
a) The flow rate was varied at ±0.2 ml/min.  
  Standard solution  was prepared and analysed using the varied flow rates along 
with method flow rate and the chromatograms were recorded. The results are 
shown in table 12. 
  Chromatogram showing Robustness-Flow variation (0.8ml/min) of Telmisartan 
and Hydrochlorothiazide. 
Fig No  : 4.47 
 
Chromatogram showing Robustness-Flow variation (1.2ml/min) of Telmisartan and 
Hydrochlorothiazide. 
Fig No :4.48 
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B)  COLUMN TEMPERATURE: 
 
Preparation of Standard Solution :            
                   Accurately 80 mg of Telmisartan and 25 mg of Hydrochlorothiazide were 
weighed separately and transferred into two 100ml volumetric flasks, about 70ml of 
diluent (ACN:MET)was added to two flasks and sonicated for 5 minutes to dissolve it. 
The volume was made up with mobile phase. The solutions were filtered through 0.45µm 
membrane filter (Stock solutions). 
                  From above solutions 5 ml Telmisartan stock solution and 5ml of 
Hydrochlorothiazide  were  pipetted out  and  transferred  into  50 ml of volumetric flask 
and the volume was made up with mobile phase. The solution was filtered through 
0.45µm membrane filter. 
                   Inject 20µl of the blank solution and the standard solution  for five times and 
analysed using the varied Mobile phase composition along with the actual mobile phase 
composition in the method and calculate the %RSD for the area of five replicate injections. 
The chromatograms are as shown in Fig No: 4.48 to 4.49 and the results are tabulated shown 
in Table No: 13. 
    %RSD Formula:  (σ /µ)*100 
 
Acceptance criteria: 
Relative standard deviation (RSD) of areas of Telmisartan  and Hydrochlorothiazide from 
five standard chromatograms in all the flow rate variation and mobile phase composition 
should not be more than 2.0 %. 
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ROBUSTNESS  COLUMN TEMPERATURE MINUS (-5˚C)  
Fig No :4.49 
 
 
ROBUSTNESS COLUMN TEMPERATURE PLUS (+5˚C) 
Fig No: 4.50 
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Table showing Robustness results for change in flow rate and mobile phase of 
Telmisartan  and  Hydrochlorothiazide. 
Table No  : 13 
  
 
 
 
Flow rate 
Inj. Sample Area        Plate count Tailing          
RT 
0.8ml/min 
 
     Telmisartan 9609688               2909 1.3 
      
10.99 
       Hydrochlorothiazide 3629910               3007 1.6 
       
3.289 
           1.2ml/min 
1. 
    Telmisartan 6842795               2393 1.4 
      
7.908 
         Hydrochlorothiazide 2585038                2605 1.6 
       
2.353 
Column 
tttemperature  
variation 
 
+5˚C 
 
       Telmisartan 8011693               2673 1.3 
      
8.660 
           Hydrochlorothiazide 3029841               2649 1.6 
      
2.569 
 -5˚C 
 
          Telmisartan 9609688               2909 1.3 
     
10.996 
            Hydrochlorothiazide 3629910               3007 1.6 
      
3.289 
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4.7.  Forced degradation studies: 
               Forced degradation studies were carried out on the sample preparation of 
Telmisartan and Hydrochlorothiazide and the degradation was evaluated by calculating 
the % degradation of Telmisartan and Hydrochlorothiazide  in comparison with 
unstressed sample preparation.  
The following are the stress conditions which were followed for forced degradation 
studies: 
1. Acid Degradation 
2. Alkali Degradation 
3. Thermal Degradation 
4. Photolytic 
 
4.7.1 Acid Stress degradation:  
Test preparation was subjected to acid stress degradation by treating the sample with 
hydrochloric acid . The % degradation was evaluated by calculating the % assay and by 
comparing the assay results with the assay of unstressed sample. 
Test preparation: 
Treated with 2N HCL: 
Weighed and transferred  sample  equivallent to  80 mg Telmisartan and 25 mg  of 
Hydrochlorothiazide  into 100 ml volumetric flask, added 70ml of diluent a    nd 
sonicated for 5 minutes.Then take 5 ml and transferred into 50 ml volumetric flask , 
added 30 ml of diluent with intermittent shaking, 5ml of 2N Hydrochloric acid is added 
and heated for 2hrs on a water bath at 80°C. Cool and neutralized with 5ml of 2N sodium 
hydroxide.  
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Chromatogram showing degradation of telmisartan and hydrochlorothiazide by 
acid 
FigNO:4.51 
 
4.7.2 Alkali stress degradation:  
Test preparation was subjected to alkali stress degradation by treating the sample with 
sodium hydroxide. The % degradation was evaluated by calculating the % assay and by 
comparing the assay results with the assay of unstressed sample.  
Test preparation: 
Treated with 2N NaOH: 
Weighed and transferred sample equivalent to 80 mg of telmisartan and 25 mg of 
Hydrochlorothiazide into 100 ml volumetric flask. Then transferred 5 ml of this solution 
into 50 ml of volumetric flask  and added 30 ml of diluent  and sonicated for 5 minutes 
with intermittent shaking, 5ml of 2N NaOH is added and heated for 2hrs on a water bath 
at 80°C. Cool and neutralized with 5ml of 2N HCL.  
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Chromatogram showing degradation of telmisartan and hydrochlorothiazide by 
base 
Fig NO:4.52 
 
 4.7.3 Thermal stress degradation: 
Test preparation was subjected to thermal treatment (80°C) for sufficient time. The % 
degradation was evaluated by calculating the % assay and by comparing the assay results 
with the assay of unstressed sample.  
Test preparation: 
Weighed and transferred sample equivalent to 80 mg Telmisartan and 25 mg 
Hydrochlorothiazide   into 100 ml volumetric flask,   then added diluents 70 ml and make 
upto the mark. Then 5 ml of this transferred into 50 ml volumetric flask.(which was kept 
in hot air oven previously at 80°C for 3 hours) added diluents and sonicate for 5 minutes 
and made upto the mark. 
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Chromatogram showing degradation of telmisartan and hydrochlorothiazide by 
thermal stress 
Fig NO:4.53 
 
 
4.7.4 Photolysis: 
Test preparation was subjected to UV light 365nm for 8hrs. The % degradation was 
evaluated by calculating the % assay and by comparing the assay results with the assay of 
unstressed sample. 
 Test preparation: 
Weighed and transferred  sample equivalent to 80 mg of Telmisartan and 25 mg of 
Hydrochlorothiazide  into 100 ml volumetric flask.Then make upto the mark and then 
take 5 ml of this solution and transferred into 50 ml volumetric flask. Then about 30 ml 
of diluents was added and sonicate for 5 minutes andmade upto the mark  with diluent 
and mixed well and kept aside under the UV light at 271nm for 8hrs. Inject 10µl of 
sample solution into HPLC system to obtain chromatogram. 
 
 
 
Chapter: 4                                                                                             Experimental  Part 
 
RVS College of Pharmaceutical Sciences, Coimbatore Page 93 
Chromatogram showing degradation of telmisartan and hydrochlorothiazide by 
light 
Fig NO:4.54 
 
 
% DEG formula: 
                    AT               WS           DT     average wt                     
 --------------- x ----------x --------- x                 × potency of drug 
           AS              DS           WT            L.C       
Where,   
 AT = Peak Area of sample solution. 
 AS = Peak Area of standard solution. 
 WS = Weight of working standard taken in mg 
 WT = Weight of sample taken in mg  
 DS = Dilution of Standard solution  
 DT = Dilution of sample solution 
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Table showing %Degradation of Telmisartan and Hydrochlorothiazide 
Table.NO.13  
 
S.NO 
 
Degradation 
parameter 
 
             Telmisartan 
 
Hydrochlorothiazide 
Peak Area %DEG %Assa
y 
Peak Area %DEG %Assa
y 
 
    1. 
 
Acid 
 
7812474 
 
2.3 
 
96.7 
 
2912560 
 
3.9 
 
95.1 
   
   2. 
 
Base 
 
 
5083632 
 
29.5 
 
69.5 
 
 
2474534 
 
14.6 
 
84.3 
 
   3. 
 
Thermal 
 
 
7865379 
 
1.8 
 
97.7 
 
2919833 
 
1.2 
 
97.8 
 
   4. 
 
Photolytic 
 
79657456 
 
2.2 
 
96.8 
 
2819425 
 
2.3 
 
96.7 
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                                         RESULTS AND DISCUSSION 
 
In the present work a new method development and validation was carried out for the 
estimation of Telmisartan and Hydrochlorothiazide by RP-HPLC technique. The wavelength 
selection was made at 271 nm since all the two compounds maximum absorbance in UV 
spectrum as reported in the literature is in 271 nm.  
 
 
5.1.Method development: : For the method development several trials were carried out and 
reported. These leads to the optimized chromatographic conditions for the estimation of 
Telmisartan and Hydrochlorothiazide in pharmaceutical dosage form.  By  Inertsil ODS 3V 
(4.6mm×150,5µm) column eluted with mobile phase acetonitrile : trifluoro acetic acid buffer 
(30:70) at a flow rate of 1 ml/ min and a detection wavelength of 271 nm with injection 
volume of 20 µl at ambient(25°C) temperature afforded the best results.  
FIXED CHROMATOGRAPHIC CONDITION 
Table No: 14 
OPTIMIZED CHROMATOGRAPHIC CONDITIONS 
Mode of separation isocratic elution 
Mobile phase Solvent-A: Trifluoro acetic acid pH-3 
Solvent-B: ACN(70:30) 
Column Inertsil ODS 3V (4.6 x 150mm, 5 µm 
) 
Flow rate 1 mL/ min 
Detection  Wavelength 271 nm 
Injection volume 20 µl 
Column oven temperature Ambient(30°C) 
Run time 12 min 
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Benefits of my method compared to previous methods: 
         The retention times of Telmisartan and Hydrochlorothiazide were 2.7 and  9.8 mins. 
And no internal standard used for this estimation. The calibration curve shows excellent 
linearity over the concentration range for Telmisartan and hydrochlorothiazide were 8-
120µg/ml and 2.5-37.5µg/ml.The mobile phase ratio of buffer and Acetonitrile was 70:30. 
    So this method is said to be economical and sensitive. 
 
Table showing comparison of previous method to proposed method:Table NO:15 
 
 
 
Method 
 
Column 
 
Mobile Phase  
 
Mobile 
phase 
ratio 
 
     pH 
 
Linearity range 
 
Retension 
Time 
 
Reported 
method 1 
 
 
 
 
 
 
 
 
Reported 
method 2 
 
 
 
 
 
 
 
Proposed 
method 
 
ACE  
C18 
(250cm 
×4.6) 
 
 
 
 
 
 
Hypersil 
gold(25
cm×4.6
mm) 
 
 
 
 
 
Inertsil 
ODS 
(4.6x15
0 mm 
,5µm 
 
Sodium 
perchlorate 
monohydrate: 
Acetonitrile 
 
 
 
 
 
 
Potassium 
dihydrogen 
phosphate: 
Acetonitrile 
 
 
 
 
 
 
Trifluoro acetic 
acid : 
Acetonitrile 
 
55:45 
 
 
 
 
 
 
 
 
 
65:35 
 
 
 
 
 
 
 
 
 
70:30 
 
   3.0 
 
Adjusted 
with 
trifluoro 
acetic acid 
 
 
 
 
5.5  
 
 
 
 
 
 
 
 
 
3.0 
 
Telmisartan-
140-260µg/ml 
and  
 
Hydrochlorothia
zide17. 5-
32.5µg/ml 
 
 
 
Telmisartan-
24.12-
56.27µg/ml 
Hydrochlorothia
zide-6-
22.4µg/ml 
 
 
 
Telmisartan-8-
120 µg/ml and 
 
Hydrochlorothia
zide – 2.5-
37.5µg/ml 
 
Telmisartan-
11.26 
 
Hydrochlorothi
azide-3.17 
 
 
 
 
 
Telmisartan-
11.72 
 
 
Hydrochlorothi
azide-3.71 
 
 
 
Telmisartan -
9.8 
 
Hydrochlorothi
azide-2.73 
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5.2. METHOD VALIDATION: 
After method development, the validation of the current method has been performed in 
accordance with USP requirements for assay determination, which include accuracy, 
precision, selectivity, linearity and range, robustness and ruggedness. 
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Table showing Summary of results of method validation for Telmisartan    and 
Hydrochlorothiazide.Table no 16 
 
 
 
 
 
 
S. No Parameter Requirement results Acceptance      
criteria 
   Telmisartan Hydrochlorothiazide  
 
System 
suitability 
RT 9.771 2.784  
1. 
Tailing factor 1.4 1.5 NMT 2 
 
 Plate count     3340.33 3959 NLT 2000 
  %RSD 0.35 0.4  
2. Assy Assay value 99.56% 99.1 98-102% 
3. Accuracy % Recovery 98.965 98.84% 98-102% 
4.  System Precision %RSD 
0.31 0.3 NMT 2% 
 
Method 
Precision %RSD 
0.4 0.39 NMT2% 
5. Specificity  No interference  
Pass Pass No interference 
6. Linearity Correlation 
coefficient 0.999 0.999 NLT 0.999 
7. Range Concentration 8-120µg/ml 2.5-37.7µg/ml Nil 
8. Robustness %RSD 0.35 0.37 NMT 2% 
9. 
Forced 
degradation  
 
Acid 
 
      Base 
      
     Thermal 
      
Photolytic 
 
%degradation Within the limit Within the limit NMT 30% 
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a.System suitability: 
 
               From the system suitability studies it was observed that % RSD of retention times 
were found to be 0.35%(Telmisartan) and 0.4%(Hydrochlorothiazide). USP tailing factor was 
found to be 1.4(Telmisartan) and 1.5(Hydrochorothiazide). Average theoretical plates are 
found to be 3340.33(telmisartan) and 3959(Hydrochlorothiazide). All the parameters were 
within the limit.  
 
b.Linearity:  
                From the Linearity data it was observed that the method was showing linearity in 
the concentration range of 8-120 µg / ml for Telmisartan and 2.5-37.5µg/ml for 
Hydrchlorothiazide. Correlation coefficient was found to be 0.9998 for Telmisartan and 
0.9996 forHydrochlorothiazide.  
 c.Precision: The RSD of peak area for standard chromatograms of system precision were 
found to be 0.31 % for Telmisartan and 0.3% for Hydrochlorothiazide , and in method  
precision it was found to be 0.4% for Telmisartan and 0.39% for Hydroclorothiazide. It 
passes method and system precision.  
 
d.Accuracy: The percentage recovery of telmisartan and hydrochlorothiazide were  98.964 
and 98.84 %.The percentage recovery of the two drugs were within the limit. 
 
e.SPECIFICITY: 
The chromatograms of standard and sample are identical with nearly same retention 
time. No interference  due to placebo and sample at the retention time of analyte which shows 
that the method was specific.  
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f.Robustness: 
As the % RSD of retention time and asymmetry were within limits for variation 
(± 5˚c) in column temperature. Hence the allowable variation in wavelength was ± 5˚c.  
  As the % RSD of retention time and asymmetry were within limits for 
variation in flow rate (± 0.2 ml). Hence the allowable flow rate should be within 0.8 ml 
to 1.2 ml.  
 
g.Forced degradation studies: 
           The % degradation of Telmisartan and Hydrochlorothiazide by various 
conditions like acid,base,thermal,photolytic were performed .The results of these 
studies were 
 
Acid stress degradation: 
       The % degradation of Telmisartan was 2.3%. The % degradation of 
Hydrochlorothiazide was 3.9.The % degradation of two drugs were within the limit. 
Alkali stress degradation: 
          The % degradation of Telmisartan was 29.5%.The % degradation of 
hydrochlorothiazide was 14.6%. The % degradation of two drugs by alkali stress were 
within the limit. 
Thermal stress degradation: 
             The % degradation of Telmisartan was 1.8%.The % degradation of 
Hydrochlorothiazide was 1.2%. The % degradation of two drugs by thermal stress were 
within the limit. 
Photolytic degradation: 
             The % degradation of Telmisartan was 2.2%.The % degradation of 
Hydrochlorothiazide was 2.3%. The % degradation of two drugs by photolysis were 
within the limit. 
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                                                                CONCLUSION 
 
 A new method is  developed  for  Simultaneous Estimation of  Telmisartan 
and Hydrochlorothiazide by RP-HPLC method. The sample preparation is 
simple and the analysis time is short. The analytical procedure is validated as 
per ICH Q2B guidelines and shown to be accurate, precise and specific and 
economic and stability indicating.  
 
 This method represents an economic and stability indicating analytical 
procedure for the simultaneous quantization of  Telmisartan and 
Hydrochlorothiazide. The method is amenable to the routine analysis of large 
numbers of samples with good precision and accuracy. 
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